glucose, (beta-d)-isomer has been researched along with Peritonitis in 238 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (3.36) | 18.7374 |
| 1990's | 47 (19.75) | 18.2507 |
| 2000's | 68 (28.57) | 29.6817 |
| 2010's | 99 (41.60) | 24.3611 |
| 2020's | 16 (6.72) | 2.80 |
| Authors | Studies |
|---|---|
| Amer, M; Avishai, E; Azulay-Debby, H; Ben-Shaanan, TL; Boshnak, N; Farfara, D; Hajjo, H; Hakim, F; Haykin, H; Kobiler, O; Koren, T; Korin, B; Krot, M; Rolls, A; Rosenblum, K; Schiller, M; Yifa, R; Zalayat, I | 1 |
| Aranda-Tavio, H; Channon, KM; Greaves, DR; Purvis, GSD | 1 |
| Cooper, D; Law, HL | 1 |
| Qian, W; Qiao, S; Shen, S; Wang, T; Xu, Z; Yan, W; Zhu, Y | 1 |
| Guo, D; Guo, R; Guo, W; Liao, H; Tao, R; Yan, Z; Yu, X; Zhu, Z | 1 |
| Arena, AC; Bernal, LPT; Cardoso, CAL; Fraga, TL; Kassuya, CAL; Leitão, MM; Lencina, JDS; Radai, JAS; Silva-Filho, SE | 1 |
| Foucras, G; Guerre, P; Guzylack-Piriou, L; Pierron, A; Tardieu, D | 1 |
| Kim, WJ; Lee, J; Yeo, J; Yoon, S | 1 |
| Carvalho, DCM; Cavalcante-Silva, LHA; Costa, PRR; Lima, ÉA; Netto, CD; Rodrigues-Mascarenhas, S | 1 |
| Albino, S; de Almeida, M; Espírito-Santo, R; Lima, M; Moura, R; Santos, V; Silva, J; Silva, P; Villarreal, C | 1 |
| Bénézech, C; Denby, L; Dobie, R; Henderson, BEP; Henderson, NC; Jackson-Jones, LH; Magalhaes, MS; Mole, DJ; Mylonas, KJ; Nixon, M; Portman, JR; Smith, P; Vermeren, MM; Vermeren, S | 1 |
| Auger, JL; Binstadt, B; Brouwers, H; Clària, J; Freysdottir, J; Garrido-Mesa, J; Giera, M; Gonzalez-Torres, M; Hardardottir, I; Huizinga, TWJ; Ioan-Facsinay, A; Jónasdóttir, HS; Kloppenburg, M; Kuipers, ME; Kwekkeboom, JC; López-Vicario, C; Norling, LV; Perretti, M; Toes, REM | 1 |
| Carvalho, DCM; de Almeida Lima, É; de Almeida Vasconcellos, MLA; de França, JS; de Sales-Neto, JM; Lima-Junior, CG; Mendes, RKS; Olegário, TR; Rodrigues-Mascarenhas, S | 1 |
| Bauer, R; Brüne, B; Fleming, I; Fulda, S; Huard, A; Knuth, AK; Mota, AC; Naeem, Z; Rappl, P; Schmid, T; Weigert, A | 1 |
| Iguchi, D; Ishimoto, T; Ito, Y; Kim, H; Kinashi, H; Kojima, H; Maruyama, S; Mizuno, M; Ozeki, T; Suzuki, Y | 1 |
| Bifulco, G; Chini, MG; D'Auria, MV; De Marino, S; Festa, C; Giordano, A; Hofstetter, RK; Maione, F; Potenza, M; Saviano, A; Sciarretta, M; Werz, O | 1 |
| Barlassina, C; Bolego, C; Braga, D; D'Avila, F; Locati, M; Maggi, A; Pepe, G; Renzi, TA; Vegeto, E; Villa, A | 1 |
| Cha, YN; Chen, Y; Choi, Y; Chung, HT; Hahn, YI; Jang, JH; Joe, Y; Kim, SH; Kim, W; Lee, HN; Lee, YH; Ngo, HK; Surh, YJ | 1 |
| Brod, S; D'Acquisto, F; Gittens, B; Gobbetti, T; Ono, M; Perretti, M | 1 |
| Belardo, C; Boccella, S; de Novellis, V; De Rosa, M; Ianaro, A; Lista, L; Panza, E; Pavone, V | 1 |
| Bilancia, R; Dehm, F; Krauth, V; Pace, S; Rossi, A; Rummler, S; Sautebin, L; Troisi, F; Weinigel, C; Werz, O | 1 |
| Arai, S; Hiramoto, E; Ito, Y; Kitada, K; Maruyama, S; Matsuo, S; Miyazaki, T; Mizuno, M; Nakano, D; Nishiyama, A; Sakata, F; Suzuki, Y; Takei, Y; Tomita, T | 1 |
| Arwood, ML; Chan-Li, Y; Collins, SL; Horton, MR; Oh, MH; Patel, CH; Powell, JD; Sun, IH; Tam, AJ | 1 |
| Benarafa, C; Burgener, SS; Candalh, C; Dahdah, A; Foretz, M; Launay, P; Lauret, E; Lucas, B; Martin, KR; Mouthon, L; Pacreau, E; Pederzoli-Ribeil, M; Thieblemont, N; Witko-Sarsat, V | 1 |
| Cha, YN; Chung, HT; Jang, JH; Joe, Y; Kim, C; Kim, K; Kim, SH; Kim, W; Suh, YG; Surh, YJ | 1 |
| Ding, Y; Kang, P; Zhang, T; Zhang, XT; Zhang, XY | 1 |
| Araújo-Júnior, JX; de Miranda, GEC; de Moura, AMA; Guedes, PMM; Jales, JT; Lucena, AMM; Nascimento, GJ; Santos, BVO; Scortecci, KC; Souto, JT; Souza, CRM | 1 |
| Kokkotou, E; Korniotis, S; Koulmanda, M; Kyriazis, P; Li, LS; Ma, L; Strom, TB; Theodorou, E; Thornley, TB | 1 |
| Iguchi, D; Ito, Y; Maruyama, S; Mizuno, M; Okada, A; Okada, H; Sakata, F; Suzuki, Y | 1 |
| Bhattacharya, J; Doran, AC; Du, J; Gusarova, G; Hook, J; Islam, MN; Kuriakose, G; Proto, JD; Rymond, CC; Sozen, E; Subramanian, M; Tabas, I; Yurdagul, A | 1 |
| Azcutia, V; Denning, TL; Flemming, S; Hilgarth, RS; Kim, W; Leary, MNO; Luissint, AC; Nusrat, A; Parkos, CA; Williams, HC | 1 |
| Bednarski, M; Bilska-Wilkosz, A; Dudek, M; Iciek, M; Knutelska, J; Kwiecień, B; Kwiecień, I; Sapa, J; Sokołowska-Jeżewicz, M; Włodek, L; Zygmunt, M | 1 |
| Allen, JE; Brombacher, F; Davies, LC; Fraser, DJ; Jenkins, SJ; Jones, SA; Liao, CT; Rosas, M; Scurr, MJ; Taylor, PR | 1 |
| Arita, M; Bamba, T; Fujieda, Y; Fukusaki, E; Guo, L; Hayashi, Y; Manno, A; Rhodes, N | 1 |
| Cha, YN; Kundu, JK; Lee, HN; Surh, YJ | 1 |
| Karmarkar, D; Rock, KL | 1 |
| Arai, H; Arita, M; Goto, T; Inoue, M; Isobe, Y; Iwamoto, R; Kubota, T; Urabe, D; Yoshioka, T | 1 |
| Aubareda, A; Bou-Gharios, G; Crowe, J; Dean, JL; Lu, X; McNamee, K; Przybycien, PM; Saklatvala, J; Williams, RO | 1 |
| Barz, D; Dehm, F; Hanke, T; Kaiser, A; Kunze, J; Lämmerhofer, M; Liening, S; Maczewsky, J; Pillong, M; Popella, SD; Sautebin, L; Schneider, G; Schubert-Zsilavecz, M; Weinigel, C; Werz, O; Wurglics, M | 1 |
| Bruzzone, S; Cuzzocrea, S; De Flora, A; Di Paola, R; Guida, L; Magnone, M; Salis, A; Scarfì, S; Sturla, L; Zocchi, E | 1 |
| Baron, RM; Chiang, N; Dalli, J; Li, Y; Quintana, C; Serhan, CN | 1 |
| Dushkin, MI; Kovshik, GG | 1 |
| Furuhashi, K; Ito, Y; Katsuno, T; Kim, H; Maruyama, S; Matsuo, S; Mizuno, M; Ozaki, T; Sato, W; Suzuki, Y; Tsuboi, N; Yasuda, K | 1 |
| Freeze, HH; He, P; Srikrishna, G | 1 |
| Banoglu, E; Barz, D; Çalışkan, B; Gerstmeier, J; Luderer, S; Maczewsky, J; Mönch, B; Pace, S; Pergola, C; Rossi, A; Sautebin, L; Weinigel, C; Werz, O | 1 |
| Benestad, HB; Bøyum, A; Carlsen, H; Iversen, PO; Knudsen, E | 1 |
| Dalli, J; Granja, T; Mirakaj, V; Rosenberger, P; Serhan, CN | 1 |
| Devanathan, V; Granja, T; Jennewein, C; Köhler, D; König, K; Marth, L; Roissant, J; Rosenberger, P; Schneider, M; Zarbock, A | 1 |
| Pace, S; Pergola, C; Rådmark, O; Rossi, A; Sautebin, L; Werz, O | 1 |
| Chadzinska, M; Homa, J; Kepka, M; Verburg-van Kemenade, BM | 1 |
| Arai, H; Arita, M; Goto, T; Inoue, M; Isobe, Y; Iwamoto, R; Matsueda, S; Urabe, D; Yokokura, Y; Yoshioka, T | 1 |
| Álvarez de La Rosa, D; Arce-Franco, M; Armas-González, E; Barreiro, O; Díaz-González, F; Domínguez-Luis, MJ; Feria, M; Herrera-García, AM; Machado, JD; Pec, MK; Sánchez-Madrid, F | 1 |
| Arnardottir, HH; Colas, RA; Dalli, J; Serhan, CN; Shinohara, M | 1 |
| Cooper, D; Gittens, BR; Wright, RD | 1 |
| Huang, Z; Liu, C; Liu, S; Liu, Y; Pang, Q; Song, S; Wu, Q; Zhang, J; Zhang, R | 1 |
| Dolganova, OM; Dushkin, MI; Khrapova, MV; Rudina, MI | 1 |
| Al Saati, T; Baillif, V; Behar, A; Cougoule, C; Dubourdeau, M; Lastrucci, C; Maridonneau-Parini, I | 1 |
| Chiang, N; Colas, RA; Dalli, J; Orr, SK; Serhan, CN | 1 |
| Alves, AK; Cavalcante-Silva, LH; Galvão, JG; Leite, JA; Morrot, A; Rodrigues-Mascarenhas, S; Rumjanek, VM; Scavone, C; Teixeira, MP | 1 |
| Alexandre-Moreira, MS; Barros, PR; Bortoluzzi, JH; da Silva Santos, M; da Silva, AE; da Silva, YKC; de Meneses Santos, R; Meneghetti, MR | 1 |
| Chadzinska, M; Kepka, M; Pijanowski, L; Szwejser, E; Verburg-van Kemenade, BM | 1 |
| Barreda, DR; Havixbeck, JJ; Hodgkinson, JW; Rieger, AM; Wong, ME | 1 |
| Hamann, A; Kenngott, EE; Liu, FD; Schwab, JM; Watzlawick, R | 1 |
| Mazur-Bialy, AI; Pocheć, E | 1 |
| Alkan, M; Burgel, PR; Candalh, C; Cassatella, MA; Martin, C; Millet, A; Mocek, J; Ohayon, D; Pederzoli-Ribeil, M; Tamassia, N; Thevenot, G; Thieblemont, N; Witko-Sarsat, V | 1 |
| Assreuy, AM; Chaves, EM; Madeira, Jda C; Nonato, DT; Pereira, MG; Quinet, YP; Sousa, PL | 1 |
| Boyken, J; Dahllöf, H; Laux-Biehlmann, A; Nagel, J; Schmidt, N; Zollner, TM | 1 |
| Chen, W; Jia, L; Liu, J; Tian, Y; Wang, J | 1 |
| Adage, T; Gerlza, T; Gschwandtner, M; Kungl, AJ; Piccinini, AM | 1 |
| Barreda, DR; Karuppannan, AK; More Bayona, JA; Trites, MJ | 1 |
| Armstrong, MG; Hall, JV; Hoover, DB; Li, C; Monroe, LL; Ozment, TR; Williams, DL; Zhang, X | 1 |
| Balza, E; Carta, S; Castellani, P; Gattorno, M; Lavieri, R; Piccioli, P; Rubartelli, A; Semino, C | 1 |
| Bitencourt, MAO; da Silva Siqueira, EM; Estrela, AB; Fernandes-Pedrosa, MF; Furtado, AA; Lima, MCJS; Lopes, NP; Silva-Júnior, AA; Souza da Silva, N; Tomaz, JC; Torres-Rêgo, M; Zucolotto, SM | 1 |
| Breyer, RM; Ji, Y; Kong, D; Lazarus, M; Liu, G; Lu, A; Nakamura, M; Shen, Y; Stratakis, CA; Yu, Y; Zuo, S | 1 |
| Cooper, D; Flak, MB; Norling, LV; Souza, PR; Thedchanamoorthy, P; Wright, RD | 1 |
| Aguiar, RP; Bersani-Amado, CA; Cardia, GFE; Cavalcante, HAO; Cuman, RKN; da Silva, EL; de Souza Silva-Comar, FM; Silva-Filho, SE; Uchida, NS; Wiirzler, LAM | 1 |
| Arnold, B; Barteczko, M; Kolaczkowska, E; Plytycz, B | 1 |
| Baginski, P; Chadzinska, M; Kemenade, BM; Kolaczkowska, E; Savelkoul, HF | 1 |
| Bramanti, P; Crisafulli, C; Cuzzocrea, S; Di Paola, R; Esposito, E; Genovese, T; Mazzon, E; Salvemini, D | 1 |
| Chadzinska, M; Savelkoul, HF; Verburg-van Kemenade, BM | 1 |
| Huang, YL; Kou, JP; Ma, L; Song, JX; Yu, BY | 1 |
| Natorska, J; Plytycz, B | 2 |
| Chadzinska, M; Kolaczkowska, E; Plytycz, B; Scislowska-Czarnecka, A; Van Rooijen, N | 1 |
| Kasuga, K; Martinod, K; Oh, SF; Pillai, PS; Porter, TF; Serhan, CN; Spite, M; Yang, R | 1 |
| Arnold, B; Kolaczkowska, E; Opdenakker, G; Piccard, H; Plytycz, B | 1 |
| Cunha, FQ; Dal-Secco, D; Fukada, SY; Girão, VC; Leite, AC; Rocha, FA | 1 |
| Adair, RM; Baranowski, JL; Bettencourt, BM; Brioni, JD; Brito, AA; Carr, TL; Cowart, MD; Cuff, CA; Esbenshade, TA; Liu, H; Manelli, AM; Marsh, KC; McPherson, MJ; Miller, TR; Rundell, L; Strakhova, MI; Vortherms, TA; Wetter, JM; Witte, DG; Yao, BB | 1 |
| Gijón, MA; Murphy, RC; Ransome, AE; Sala, A; Zarini, S | 1 |
| Cash, JL; Greaves, DR; White, GE | 1 |
| Harris, CL; Hepburn, N; Ito, Y; Matsuo, S; Mizuno, M; Mizuno, T; Morgan, BP; Noda, Y; Yuzawa, Y | 1 |
| Arai, H; Arita, M; Inoue, M; Ogawa, S; Urabe, D; Yokokura, Y | 1 |
| Galligan, C; Takahashi, M; Tessarollo, L; Yoshimura, T | 1 |
| Arnold, B; Kolaczkowska, E; Koziol, A; Plytycz, B | 1 |
| Arnold, B; Kolaczkowska, E; Koziol, A; Opdenakker, G; Plytycz, B | 1 |
| Huang, EP; Luo, SQ; Yang, CL; Zhao, WZ | 1 |
| Fantuzzi, G; Pini, M | 1 |
| Bramanti, P; Cuzzocrea, S; Di Paola, R; Galuppo, M; Mazzon, E; Paterniti, I | 1 |
| Carlson, BA; Gladyshev, VN; Hatfield, DL; Irons, R; Kim, JY; Park, JM; Sano, Y; Sengupta, A; Yoo, MH | 1 |
| Bian, Z; Chen, X; Chen, YY; Guo, YL; Liu, DQ; Liu, Y; Zen, K; Zhang, CY | 1 |
| Bystrom, J; Farrow, SN; Gilroy, DW; Navarro-Xavier, RA; Newson, J; Silveira, VL | 1 |
| Galgani, M; Matarese, G | 1 |
| Matsushima, H; Miyazaki, T; Nishibu, A; Ogawa, Y; Takashima, A; Tanaka, H | 1 |
| Dalli, J; Edelman, A; Hayhoe, RP; Perretti, M; Rosignoli, G | 1 |
| Hung, ND; Kim, MR; Sok, DE | 3 |
| Kornerup, KN; Liu, WL; Page, CP; Pitchford, SC; Salmon, GP | 1 |
| Alexandre-Moreira, MS; Augusto, CV; Barreiro, EJ; da Silva, YK; de Albuquerque Melo, GM; de Castro Barbosa, ML; de Lima Matos Freire Dias, T; de Queiroz, AC; Júnior, WB; Lima, LM | 1 |
| Fu, N; Liu, Y; Lu, X; Pan, Q; Wu, S; Zheng, J; Zhu, P | 1 |
| Anderson, G; Buckley, CD; Bystrom, J; Gilroy, DW; Hou, TZ; Parnell, SM; Qureshi, O; Sherlock, JP | 1 |
| Bratton, DL; Fernandez-Boyanapalli, R; Frasch, SC; Henson, PM; Riches, DW; Vandivier, RW | 1 |
| Chiang, N; Fredman, G; Krishnamoorthy, S; Recchiuti, A; Serhan, CN | 1 |
| Arai, H; Arita, M; Nakanishi, H; Taguchi, R; Tani, Y; Yamada, T | 1 |
| Kolaczkowska, E; Majka, A; Mazur-Bialy, AI; Plytycz, B; Wojtas, L | 1 |
| Baroja-Mazo, A; Lopez-Castejón, G; Pelegrín, P | 1 |
| Abu-Zidan, FM; Al-Salam, S; Berger, D; Branicki, FJ; Padmanabahn, KR; Torab, FC | 1 |
| Brommer, B; Brown, S; Klein, G; Köhler, D; Laucher, S; Meisel, C; Mirakaj, V; Rosenberger, P; Schwab, JM; Skutella, T; Steinl, C | 1 |
| Bazhanov, N; Choi, H; Lee, RH; Oh, JY; Prockop, DJ | 1 |
| Chaikof, EL; Dougherty, A; Haller, CA; Krishnamurthy, VR | 1 |
| Alexandre-Moreira, MS; Alves, MA; Barreiro, EJ; Beraldo, H; Castellano, EE; Júnior, WB; Lima, LM; Parrilha, GL; Perez-Rebolledo, A; Piro, OE | 1 |
| Barbosa-Filho, JM; Bitencourt, MAO; Dantas, GR; Lira, DP; Miranda, GEC; Santos, BVO; Souto, JT | 1 |
| Aguilar-Ruiz, SR; García-Zepeda, EA; González-Domínguez, É; González-Pérez, G; Meraz-Ríos, MA; Narváez, J; Sánchez-Torres, C; Torres-Aguilar, H; Vargas-Ayala, G | 1 |
| Bystrom, J; Camon, EB; Farrow, S; Gilroy, DW; Lovering, RC; Newson, J; Shah, S; Stables, MJ | 1 |
| Bian, Z; Guo, Y; Ha, B; Liu, Y; Zen, K | 1 |
| Kolaczkowska, E; Natorska, J; Stankiewicz, E; Wypasek, E | 1 |
| Arai, H; Arita, M; Fujihara, T; Inoue, M; Isobe, Y; Iwamoto, R; Masuda, K; Matsueda, S; Nakanishi, H; Sasaki, K; Taguchi, R; Urabe, D | 1 |
| Harris, CL; Ito, Y; Matsuo, S; Mizuno, M; Mizuno, T; Morgan, BP; Okada, N; Suzuki, Y | 1 |
| Boudinot, P; Chadzinska, M; Derks, W; Levraud, JP; Lidy Verburg-van Kemenade, BM; Scheer, M; van der Aa, LM | 1 |
| Leite, FC; Leite, JA; Piuvezam, MR; Rodrigues Mascarenhas, S; Rodrigues, LC; Vasconcelos, RM | 1 |
| Chiang, N; Dalli, J; Fredman, G; Li, Y; Serhan, CN | 1 |
| Alexandre-Moreira, MS; Barbosa Brito da Matta, C; Barbosa-Filho, JM; Cavalcante-Silva, LHA; De Araújo, MV; De Miranda, GEC; De Oliveira Santos, BV; Pereira de Lira, D | 1 |
| Kolaczkowska, E; Mazur-Bialy, AI; Plytycz, B | 1 |
| Barreda, DR; Havixbeck, JJ; Konowalchuk, JD; Lund, JM; Rieger, AM; Robbins, JS; Smith, MK | 1 |
| Barbera, A; Caputi, AP; Centorrino, T; Chatterjee, PK; Ciccolo, A; Cuzzocrea, S; Dugo, L; Fulia, F; Mazzon, E; McDonald, MC; Serraino, I; Thiemermann, C | 1 |
| Arita, M; Bannenberg, G; Devchand, PR; Gronert, K; Hong, S; Moussignac, RL; Serhan, CN | 1 |
| Bulger, EM; Cuschieri, J; Garcia, I; Gourlay, D; Jelacic, S; Maier, RV; Staudenmeyer, K | 1 |
| Crowley, H; Huber, BT | 1 |
| Cooper, D; Hall, JC; McCauley, R; Platell, C; Yao, V | 2 |
| Caputi, AP; Catalano, P; Cuzzocrea, S; Di Paola, R; Genovese, T; Li, JH; Massuda, E; Xu, W; Zhang, J | 1 |
| Goris, RJ; Hendriks, T; van der Meer, JW; Volman, TJ | 1 |
| Autore, G; Britti, D; Cuzzocrea, S; Di Paola, R; Genovese, T; Marzocco, S; Pinto, A; Scollo, G; Sorrentino, R | 1 |
| Britti, D; Caputi, AP; Cuzzocrea, S; De Sarro, A; Di Paola, R; Dugo, L; Genovese, T; Rossi, A; Sautebin, L; Sciarra, G; Serraino, I | 1 |
| Bannenberg, G; Bauman, JG; Devchand, PR; Gronert, K; Guilford, WJ; Moussignac, RL; Parkinson, JF; Perez, HD; Schmidt, BA; Serhan, CN; Subramanyam, B | 1 |
| Hall, JC; Platell, C; Yao, V | 1 |
| Plytycz, B; Stankiewicz, E; Wypasek, E | 1 |
| Phelps, DS; Thomas, NJ; Umstead, TM | 1 |
| Bilecki, W; Chadzinska, M; Pierzchala-Koziec, K; Plytycz, B; Przewlocka, B; Przewlocki, R; Scislowska-Czarnecka, A; Starowicz, K | 1 |
| Hamazaki, T; Kanada, S; Takenaka, M; Watanabe, S | 1 |
| Chadzinska, M; Pierzchala-Koziec, K; Plytycz, B; Scislowska-Czarnecka, A | 1 |
| Bannenberg, G; Hickey, L; Keledjian, R; Larvie, M; Levy, BD; Morris, AJ; Petasis, NA; Serhan, CN | 1 |
| Ariel, A; Fredman, G; Gotlinger, KH; Hong, S; Li, PL; Serhan, CN; Tang, WX; Wang, W | 1 |
| D'Amico, M; Di Filippo, C; Getting, SJ; Perretti, M | 1 |
| Bikádi, Z; Hazen, SL; Lockwood, SF; Penn, MS; Zsila, F | 1 |
| Arnold, B; Chadzinska, M; Kolaczkowska, E; Opdenakker, G; Plytycz, B; Scislowska-Czarnecka, A | 1 |
| Ikeda, K; Shimizu, Y; Sugahara, S; Yamamoto, S | 1 |
| Cai, SX; Liang, HP; Liu, DB; Wang, ZP; Xu, X | 1 |
| Caldon, N; Gao, L; Gyurko, R; Kantarci, A; Siqueira, CC; Van Dyke, TE | 1 |
| Arita, M; Elangovan, S; Hong, S; Oh, SF; Percarpio, KB; Serhan, CN; Siegelman, J; Tjonahen, E | 1 |
| Biedroń, R; Bobek, M; Kontny, E; Kurnyta, M; Marcinkiewicz, J; Maśliński, W | 1 |
| Kubes, P; Mullaly, SC | 1 |
| Arita, M; Chiang, N; Schwab, JM; Serhan, CN | 1 |
| Calixto, JB; Echevarria-Lima, J; Ferreira, SC; Leite, DF; Rumjanek, VM | 1 |
| Caminiti, R; Cuzzocrea, S; Di Bella, P; Di Paola, R; Esposito, E; Genovese, T; Malleo, G; Mazzon, E; Muià, C | 1 |
| Arnold, B; Kolaczkowska, E; Kozakiewicz, E; Lelito, M; Plytycz, B; van Rooijen, N | 1 |
| Gilson, JF; Kamerath, CD; Leypoldt, JK | 1 |
| Bramanti, P; Caminiti, R; Cuzzocrea, S; Di Paola, R; Esposito, E; Genovese, T; Malleo, G; Mazzon, E | 1 |
| Arnold, B; Kolaczkowska, E; Opdenakker, G | 1 |
| Carlton, MB; Cash, JL; Colledge, WH; Dixon, JP; Doran, J; Greaves, DR; Hart, R; Hendrick, AG; Russ, A | 1 |
| Chan, L; Fantuzzi, G; Gove, ME; Pini, M; Sennello, JA; van Baal, JW | 1 |
| Joyce, LD; Lillehei, RC; Mauer, HG; Smith, JM | 1 |
| Doherty, NS; Griffiths, RJ; Hakkinen, JP; Milici, AJ; Scampoli, DN | 1 |
| Arányi, P; Erdö, F; Németh, K; Székely, JI; Török, K | 1 |
| Leduc, D; Pretolani, M; Vargaftig, BB; Zuany-Amorim, C | 1 |
| Demling, R; Ikegami, K; LaLonde, C; Nayak, U | 1 |
| Demling, R; Ikegami, K; Lalonde, C; Picard, L | 1 |
| Demling, R; Ikegami, K; LaLonde, C; Nayak, U; Picard, L | 1 |
| Dijkstra, CD; Huitinga, I; Joosten, LA; van de Langerijt, AG; van den Berg, WB; Van Lent, PL | 1 |
| Ansell, J; Appollina, MA; Argentieri, D; Hageman, W; Nguyen, VN; Ohemeng, KA; Schwender, CF; Singer, M; Steber, M | 1 |
| Currie, JL; Isakson, PC; Rao, TS; Shaffer, AF | 1 |
| Campbell, C; Daryani, R; Demling, R; Knox, J; Lalonde, C; Youn, YK | 3 |
| Amar, M; Amit, N; Hakim, J; Pham Huu, T | 1 |
| Boughton-Smith, NK; Ghelani, A | 1 |
| Andersson, R; Deng, X; Wang, X | 1 |
| Fredholm, BB; Hedqvist, P; Raud, J; Zhang, Y | 1 |
| Byrum, RS; Goulet, JL; Griffiths, RJ; Koller, BH | 1 |
| Caputi, AP; Cuzzocrea, S; Falciani, M; Filippelli, A; Rossi, F; Zingarelli, B | 1 |
| Cuzzocrea, S; Flower, RJ; Getting, SJ; Lim, LH; Perretti, M; Salzman, AL; Szabó, C; Zingarelli, B | 1 |
| Calapai, G; Campo, GM; Caputi, AP; Costantino, G; Crisafulli, C; Cuzzocrea, S; Di Rosa, M; Nava, F; Rizzo, A; Sautebin, L; Zingarelli, B | 1 |
| Ajuebor, MN; Bowers, K; Christie, M; Flower, RJ; Hannon, R; Perretti, M; Verity, A | 1 |
| Carmeliet, P; Collen, D; French, EL; Ploplis, VA; Plow, EF | 1 |
| Dinarello, CA; Fantuzzi, G | 1 |
| Inoue, K; Kin, H; Kubota, Y; Ogura, M; Takaoka, M; Tsuji, K; Yamamoto, S; Yanagitani, K | 1 |
| Caputi, AP; Costantino, G; Cuzzocrea, S; Zingarelli, B | 1 |
| Ajuebor, MN; Flower, RJ; Perretti, M; Szabó, C; Virág, L | 1 |
| Ajuebor, MN; Das, AM; Perretti, M; Szabó, C; Virág, L | 1 |
| Caputi, AP; Ciriaco, E; Costantino, G; Cuzzocrea, S; de Sarro, A; de Sarro, G; Laurà, R; Mazzon, E | 1 |
| Caputi, AP; Costantino, G; Cuzzocrea, S; Mazzon, E | 1 |
| Caputi, AP; Costantino, G; Cuzzocrea, S; Sottile, A; Teti, D; Zingarelli, B | 1 |
| Carlsson, O; Rippe, B | 1 |
| Cheadle, WG; Daly, J; Kotwal, GJ; Mahesh, J | 1 |
| Caputi, AP; Costantino, G; Cuzzocrea, S; Filippelli, A; Imperatore, F; Luongo, C; Mangoni, G; Mazzon, E; Rossi, F; Scafuro, MA | 1 |
| Byrum, RS; Goulet, JL; Key, ML; Koller, BH; Nguyen, M; Wagoner, VA | 1 |
| Hiyama, E; Imamura, Y; Matsuura, Y; Murakami, Y; Sakashita, Y; Sugahara, Y; Takesue, Y; Yokoyama, T | 1 |
| Del Soldato, P; Fiorucci, S; Flower, RJ; Paul-Clark, M; Perretti, M | 1 |
| Kolaczkowska, E; Plytycz, B; Seljelid, R | 2 |
| Barbera, A; Caputi, AP; Centorrino, T; Ciccolo, A; Cuzzocrea, S; Dugo, L; Fonti, MT; Mazzon, E | 1 |
| Azuma, Y; Ohura, K; Shinohara, M; Wang, PL | 1 |
| Kolaczkowska, E; Plytycz, B; Seljelid, R; Shahzidi, S; van Rooijen, N | 1 |
| Bensard, DD; Calkins, CM; Karrer, FM; McIntyre, RC; Partrick, DA | 1 |
| Caputi, AP; Chatterjee, PK; Cuzzocrea, S; Dugo, L; Fulia, F; Mazzon, E; McDonald, MC; Paola, RD; Thiemermann, C | 1 |
| Hau, T; Hoffman, R; Joyce, LD; Lillehei, RC; Simmons, RL | 1 |
| Hau, T; Joyce, LD; Lillehei, RC; Simmons, RL | 1 |
| Bast, A; van der Poel, KI; van der Vliet, A | 1 |
| Abe, M; Goya, T; Muranishi, H; Nagata, N; Shigematsu, N; Takahashi, H | 1 |
| Hamada, K; Kashiba, S; Kita, E; Konishi, M; Kunimatsu, M; Mikasa, K; Narita, N; Sawaki, M | 1 |
| Bleichrodt, RP; Manson, WL; Rosman, C; Wübbels, GH | 1 |
| Parente, L; Perretti, M; Solito, E | 1 |
| Amar, M; Amit, N; Babin-Chevaye, C; Hakim, J; Huu, TP; Pasquier, C; Scoazec, JY | 1 |
| Briantais, MJ; Brivet, M; Galanaud, P; Khellaf, A; Lebrun, L; Pelletier, G | 1 |
| Blackham, A; Griffiths, RJ; Li, SW; Wood, BE | 1 |
| Beaver, TH; Chan, KY; Diekema, KA; Dinerstein, RJ; Doherty, NS | 1 |
| Goris, RJ; Koopman, JP; Mollen, RM; van Bebber, IP | 1 |
| Dowling, RL; Gans, KR; Kerr, JS; Lundy, SR; Mackin, WM; Stevens, TM | 2 |
| Bahrami, S; Goris, RJ; Lieners, C; Redl, H; Schlag, G; van Bebber, IP | 1 |
| Beaubien, BC; Collins, PD; Hsuan, J; Jose, PJ; Totty, NF; Waterfield, MD; Williams, TJ | 1 |
| Adam, A; Bourdon, V; Damas, J; Remacle-Volon, G | 1 |
| Dowling, RL; Gans, KR; Kerr, JS; Lundy, SR; Stevens, TM | 1 |
| Goitsuka, R; Hasegawa, A; Hirota, Y; Tsuji, M | 1 |
| Eckert, R; Jüttner, U; von Baehr, R; Zimmermann, G | 1 |
| Fry, DE; Naff, GB; Schirmer, JM; Schirmer, WJ | 1 |
| Forrest, MJ; Jose, PJ; Williams, TJ | 1 |
| do Nascimento, NG; Hassimotto, NM; Lajolo, FM; Moreira, V; Souto, PC; Teixeira, C | 1 |
1 review(s) available for glucose, (beta-d)-isomer and Peritonitis
| Article | Year |
|---|---|
Molecular mechanisms involved in the inhibition of neutrophil locomotion by tumor cells.
Topics: Animals; Anti-Inflammatory Agents; Biological Factors; Chemotaxis, Leukocyte; Humans; Inflammation; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred BALB C; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Peritonitis; Phagocytosis; Respiratory Burst; Rosette Formation; Tumor Cells, Cultured; Zymosan | 1993 |
237 other study(ies) available for glucose, (beta-d)-isomer and Peritonitis
| Article | Year |
|---|---|
Insular cortex neurons encode and retrieve specific immune responses.
Topics: Animals; Colitis; Colon; Dextran Sulfate; Female; Immunity; Inflammation; Insular Cortex; Male; Mice; Mice, Inbred C57BL; Neurons; Peritoneum; Peritonitis; Synapses; Zymosan | 2021 |
Bruton's TK regulates myeloid cell recruitment during acute inflammation.
Topics: Agammaglobulinaemia Tyrosine Kinase; Animals; Chemokines; Inflammation; Mice; Myeloid Cells; NF-kappa B; Peritonitis; Proto-Oncogene Proteins c-akt; Zymosan | 2022 |
Methods for Assessing the Effects of Galectins on Leukocyte Trafficking and Clearance.
Topics: Animals; Cell Movement; Galectins; Humans; Inflammation; Leukocytes; Peritonitis; Zymosan | 2022 |
Card9 protects fungal peritonitis through regulating Malt1-mediated activation of autophagy in macrophage.
Topics: Adaptor Proteins, Signal Transducing; Animals; Autophagy; CARD Signaling Adaptor Proteins; Macrophages; Mice; Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein; Mycoses; Peritonitis; Zymosan | 2022 |
Ibrutinib suppresses the activation of neutrophils and macrophages and exerts therapeutic effect on acute peritonitis induced by zymosan.
Topics: Adjuvants, Immunologic; Animals; Macrophages; Mice; Neutrophils; Peritonitis; Phospholipase C gamma; Zymosan | 2022 |
Analgesic and anti-inflammatory potential of ethanolic extract from Serjania erecta leaves.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; BCG Vaccine; Carrageenan; Disease Models, Animal; Edema; Ethanol; Formaldehyde; Hyperalgesia; Mice; Peritonitis; Plant Extracts; Pleurisy; Sapindaceae; Zymosan | 2023 |
Zymosan-Induced Murine Peritonitis Is Associated with an Increased Sphingolipid Synthesis without Changing the Long to Very Long Chain Ceramide Ratio.
Topics: Animals; Ceramides; Inflammation; Mice; Peritonitis; Sphingolipids; Zymosan | 2023 |
Tannic acid-based nanogel as an efficient anti-inflammatory agent.
Topics: Animals; Anti-Inflammatory Agents; Boronic Acids; Cell Line; Cytokines; Disease Models, Animal; Female; Mice; Nanogels; Neutrophils; Peritonitis; Reactive Oxygen Species; Tannins; Zymosan | 2020 |
The pterocarpanquinone LQB 118 inhibits inflammation triggered by zymosan in vivo and in vitro.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Cells, Cultured; Cytokines; Disease Models, Animal; Female; Humans; Inflammation; Inflammation Mediators; Macrophages; Mice; Naphthoquinones; Peritoneum; Peritonitis; Pterocarpans; Zymosan | 2020 |
(E)-2-Cyano-3-(1
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cytokines; Edema; Macrophages; Male; Mice; Peritonitis; Zymosan | 2020 |
Stromal Cells Covering Omental Fat-Associated Lymphoid Clusters Trigger Formation of Neutrophil Aggregates to Capture Peritoneal Contaminants.
Topics: Acute Disease; Animals; Appendicitis; Cell Communication; Chemokine CXCL1; Epithelial Cells; Epithelium; Escherichia coli; Extracellular Traps; Female; Gene Expression; Humans; Lymphocytes; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophil Infiltration; Neutrophils; Omentum; Peritonitis; Protein-Arginine Deiminase Type 4; Sequence Analysis, RNA; Single-Cell Analysis; Stromal Cells; Tissue Culture Techniques; Zymosan | 2020 |
Anti-Inflammatory and Proresolving Effects of the Omega-6 Polyunsaturated Fatty Acid Adrenic Acid.
Topics: Animals; Anti-Inflammatory Agents; Arachidonic Acid; Arthritis, Experimental; Cells, Cultured; Fatty Acids, Omega-6; Fatty Acids, Unsaturated; Humans; Leukotriene B4; Lipidomics; Macrophages; Male; Mice; Mice, Transgenic; Neutrophils; Peritoneal Lavage; Peritonitis; Primary Cell Culture; THP-1 Cells; Zymosan | 2020 |
Morita-Baylis-Hillman Adduct 2-(3-Hydroxy-2-oxoindolin-3-yl)acrylonitrile (ISACN) Modulates Inflammatory Process In vitro and In vivo.
Topics: Acrylonitrile; Animals; Anti-Inflammatory Agents; Cell Movement; Cells, Cultured; Cytokines; Disease Models, Animal; Female; Inflammation Mediators; Macrophages, Peritoneal; Mice; Neutrophil Infiltration; Neutrophils; Peritonitis; Zymosan | 2021 |
Apoptotic Cells induce Proliferation of Peritoneal Macrophages.
Topics: Animals; Apoptosis; Cell Proliferation; Cells, Cultured; Coculture Techniques; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Peritonitis; Phagocytosis; Zymosan | 2021 |
C1 inhibitor mitigates peritoneal injury in zymosan-induced peritonitis.
Topics: Animals; Complement C1 Inhibitor Protein; Epithelial Cells; Epithelium; Fibrin; Fibrinogen; Male; Peritoneum; Peritonitis; Rats; Rats, Sprague-Dawley; Zymosan | 2021 |
Structure-based screening for the discovery of 1,2,4-oxadiazoles as promising hits for the development of new anti-inflammatory agents interfering with eicosanoid biosynthesis pathways.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 5-Lipoxygenase; Cell Line; Cell Survival; Cyclooxygenase 1; Dose-Response Relationship, Drug; Drug Development; Drug Evaluation, Preclinical; Eicosanoids; Enzyme Inhibitors; Humans; Male; Mice; Molecular Structure; Oxadiazoles; Peritonitis; Prostaglandin-E Synthases; Structure-Activity Relationship; Zymosan | 2021 |
Self-renewal and phenotypic conversion are the main physiological responses of macrophages to the endogenous estrogen surge.
Topics: Angiopoietin-Like Protein 4; Animals; Arginase; Cell Cycle Proteins; Cell Proliferation; Estradiol; Female; Gene Expression Profiling; Gene Expression Regulation; Immunity, Innate; Interleukin-10; Macrophage Activation; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Ovariectomy; Peritonitis; Phenotype; Transcriptome; Vascular Endothelial Growth Factor A; Zymosan | 2017 |
15-Deoxy-Δ
Topics: Animals; CD36 Antigens; Gene Expression Regulation; Heme Oxygenase-1; Humans; Jurkat Cells; Macrophages; Mice; NF-E2-Related Factor 2; Peritonitis; Phagocytosis; Prostaglandin D2; RAW 264.7 Cells; Zymosan | 2017 |
The impact of environmental enrichment on the murine inflammatory immune response.
Topics: Animals; Cecum; Disease Models, Animal; Environment; Inflammation; Ligation; Macrophages; Male; Mice; Microarray Analysis; Neutrophils; Peritonitis; Phagocytosis; Sepsis; Zymosan | 2017 |
Preclinical evaluation of the urokinase receptor-derived peptide UPARANT as an anti-inflammatory drug.
Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Cyclooxygenase 2; Dexamethasone; Edema; Male; Mice; Nitrates; Nitric Oxide Synthase Type II; Nitrites; Oligopeptides; Peritoneal Lavage; Peritonitis; Rats, Wistar; Zymosan | 2017 |
Sex differences in prostaglandin biosynthesis in neutrophils during acute inflammation.
Topics: Acute Disease; Animals; Cyclooxygenase 2; Female; Gene Expression Regulation, Enzymologic; Inflammation; Male; Mice; Neutrophils; Peritonitis; Prostaglandins; Sex Characteristics; Zymosan | 2017 |
Apoptosis inhibitor of macrophage ameliorates fungus-induced peritoneal injury model in mice.
Topics: Animals; Apoptosis Regulatory Proteins; Biomarkers; Complement Activation; Disease Models, Animal; Epithelial Cells; Humans; Macrophages; Mice, Mutant Strains; Peritoneal Dialysis; Peritoneum; Peritonitis; Phagocytosis; Receptors, Immunologic; Receptors, Scavenger; Recombinant Proteins; Scavenger Receptors, Class B; Zymosan | 2017 |
mTORC2 Signaling Selectively Regulates the Generation and Function of Tissue-Resident Peritoneal Macrophages.
Topics: Animals; Female; Flow Cytometry; Forkhead Box Protein O1; GATA6 Transcription Factor; Immunoblotting; Macrophages; Macrophages, Peritoneal; Male; Mechanistic Target of Rapamycin Complex 2; Mice; Peritonitis; Phagocytosis; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Zymosan | 2017 |
Transgenic Mice Expressing Human Proteinase 3 Exhibit Sustained Neutrophil-Associated Peritonitis.
Topics: Animals; Annexin A1; Apoptosis; Disease Models, Animal; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myeloblastin; Neutrophils; Peritoneal Cavity; Peritonitis; Phagocytosis; Sepsis; Zymosan | 2017 |
Role of heme oxygenase-1 in potentiation of phagocytic activity of macrophages by taurine chloramine: Implications for the resolution of zymosan A-induced murine peritonitis.
Topics: Animals; Antioxidants; Heme Oxygenase-1; Inflammation; Macrophages; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Mice, Knockout; Peritonitis; Phagocytes; Phagocytosis; RAW 264.7 Cells; Taurine; Up-Regulation; Zymosan | 2018 |
Forsythoside A Modulates Zymosan-Induced Peritonitis in Mice.
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Glycosides; Inflammation Mediators; Mice; Neutrophils; NF-kappa B; Peritoneal Cavity; Peritonitis; RAW 264.7 Cells; Zymosan | 2018 |
The Bisindole Alkaloid Caulerpin, from Seaweeds of the Genus
Topics: Alkaloids; Animals; Anti-Inflammatory Agents; Caulerpa; Colitis, Ulcerative; Colon; Cytokines; Dextran Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Indoles; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Peritonitis; Seaweed; Treatment Outcome; Zymosan | 2018 |
Hematopoietic Stem/Progenitor Cell Dependent Participation of Innate Lymphoid Cells in Low-Intensity Sterile Inflammation.
Topics: Animals; Bone Marrow Cells; Cell Differentiation; Cell Movement; Cell Self Renewal; Cells, Cultured; Disease Models, Animal; Female; Hematopoietic Stem Cells; Humans; Immunity, Innate; Lymphocytes; Mice; Mice, Inbred C57BL; Peritonitis; Signal Transduction; Stem Cell Niche; Zymosan | 2018 |
Anti-C5a complementary peptide mitigates zymosan-induced severe peritonitis with fibrotic encapsulation in rats pretreated with methylglyoxal.
Topics: Animals; Complement Activation; Complement C5a; Complement Inactivating Agents; Disease Models, Animal; Disease Progression; Male; Peritoneal Fibrosis; Peritoneum; Peritonitis; Pyruvaldehyde; Rats, Sprague-Dawley; Severity of Illness Index; Signal Transduction; Time Factors; Zymosan | 2018 |
Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution.
Topics: Animals; Apoptosis; Cell Line; Cells, Cultured; Humans; Inflammation; Interleukin-10; Interleukin-13; Jurkat Cells; Lipopolysaccharides; Lung Diseases; Macrophages; Mice, Inbred C57BL; Mice, Knockout; Peritonitis; Phagocytosis; T-Lymphocytes, Regulatory; Zymosan | 2018 |
Macrophage-dependent neutrophil recruitment is impaired under conditions of increased intestinal permeability in JAM-A-deficient mice.
Topics: Animals; Cell Adhesion Molecules; Cells, Cultured; Chemokine CXCL1; Disease Models, Animal; Gastrointestinal Microbiome; Humans; Intestinal Mucosa; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Neutrophil Infiltration; Neutrophils; NF-kappa B; Peritonitis; Permeability; Receptors, Cell Surface; Tight Junctions; Zymosan | 2019 |
In vivo anti-inflammatory activity of lipoic acid derivatives in mice.
Topics: Animals; Anti-Inflammatory Agents; Butyrates; Carrageenan; Edema; Injections, Intraperitoneal; Lethal Dose 50; Male; Mice; Peritonitis; Sulfhydryl Compounds; Thioctic Acid; Toxicity Tests, Acute; Zymosan | 2013 |
Distinct bone marrow-derived and tissue-resident macrophage lineages proliferate at key stages during inflammation.
Topics: Animals; Antigens, Ly; Bone Marrow Cells; Cell Lineage; Cell Proliferation; Female; Inflammation; Interleukin-4; Kinetics; Macrophage Colony-Stimulating Factor; Macrophages; Mice; Mice, Inbred C57BL; Peritonitis; Receptors, Interleukin-4; Zymosan | 2013 |
Inflammation and resolution are associated with upregulation of fatty acid β-oxidation in Zymosan-induced peritonitis.
Topics: Animals; Fatty Acids; Inflammation; Leukocytes; Male; Mice; Mice, Inbred C57BL; Peritonitis; Zymosan | 2013 |
Resolvin D1 stimulates efferocytosis through p50/p50-mediated suppression of tumor necrosis factor-α expression.
Topics: Animals; Apoptosis; Cell Line; Docosahexaenoic Acids; Down-Regulation; Humans; Inflammation; Jurkat Cells; Leukocyte Count; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred ICR; Neutrophils; NF-kappa B p50 Subunit; Peritonitis; Phagocytosis; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Zymosan | 2013 |
Microbiota signalling through MyD88 is necessary for a systemic neutrophilic inflammatory response.
Topics: Animals; Bacteria; Chemokines; Disease Models, Animal; Inflammation Mediators; Intestinal Mucosa; Intestines; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Knockout; Myeloid Differentiation Factor 88; Neutrophil Infiltration; Neutrophils; Peritonitis; Receptors, Interleukin-1; Signal Transduction; Toll-Like Receptors; Zymosan | 2013 |
Eicosapentaenoic acid is converted via ω-3 epoxygenation to the anti-inflammatory metabolite 12-hydroxy-17,18-epoxyeicosatetraenoic acid.
Topics: Animals; Arachidonic Acids; Cells, Cultured; Eicosapentaenoic Acid; Male; Mice; Mice, Inbred C57BL; Peritonitis; Zymosan | 2014 |
Heat shock protein B1-deficient mice display impaired wound healing.
Topics: Animals; Cell Cycle; Cell Proliferation; Collagen; Epithelial Cells; Exons; Fibroblasts; Gene Expression Regulation; HSP27 Heat-Shock Proteins; Interleukin-1; Interleukin-6; Mice; Peritonitis; Skin; Wound Healing; Zymosan | 2013 |
Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in vivo.
Topics: Animals; Arachidonate 5-Lipoxygenase; Binding Sites; Drug Design; Humans; Hydrophobic and Hydrophilic Interactions; Inhibitory Concentration 50; Intramolecular Oxidoreductases; Lipoxygenase Inhibitors; Male; Mice; Microsomes; Models, Molecular; Peritonitis; Prostaglandin-E Synthases; Protein Conformation; Pyrimidines; Structure-Activity Relationship; Thiazoles; Zymosan | 2013 |
Fluridone as a new anti-inflammatory drug.
Topics: Abscisic Acid; Animals; Anti-Inflammatory Agents; Aorta; Cell Proliferation; Cells, Cultured; Cyclooxygenase 1; Cyclooxygenase 2; Cytokines; Dinoprostone; Herbicides; Histamine Release; Humans; Lymphocytes; Male; Mice; Monocytes; Myocytes, Smooth Muscle; NF-kappa B; Peritonitis; Pyridones; RNA, Messenger; Zymosan | 2013 |
Plasticity of leukocytic exudates in resolving acute inflammation is regulated by MicroRNA and proresolving mediators.
Topics: Acute Disease; Animals; Apoptosis; Chemotaxis; Docosahexaenoic Acids; Gene Expression Regulation; Humans; Inflammation Mediators; Macrophages; Male; Mice; MicroRNAs; Neutrophils; NF-kappa B; Peritonitis; Phagocytosis; Sepsis; Transcription Factor AP-1; Transcription, Genetic; Zymosan | 2013 |
Effect of toll-like receptor agonists on the formation of macrophage/foam cells upon acute peritonitis in mice.
Topics: Animals; Cells, Cultured; Cholesterol; Foam Cells; Leukocyte Count; Lipid Metabolism; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Peritonitis; RNA, Double-Stranded; Toll-Like Receptors; Triglycerides; Zymosan | 2013 |
Rat adipose tissue-derived stem cells attenuate peritoneal injuries in rat zymosan-induced peritonitis accompanied by complement activation.
Topics: Adipose Tissue; Animals; Antibody-Dependent Cell Cytotoxicity; Cell Proliferation; Cells, Cultured; Coculture Techniques; Complement Activation; Disease Models, Animal; Hepatocyte Growth Factor; Humans; Injections, Intraperitoneal; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Peritonitis; Rats; Rats, Sprague-Dawley; Yeasts; Zymosan | 2014 |
N-glycosylation deficiency reduces ICAM-1 induction and impairs inflammatory response.
Topics: Animals; Cells, Cultured; Congenital Disorders of Glycosylation; Dietary Supplements; Glycosylation; Humans; Inflammation; Intercellular Adhesion Molecule-1; Mannose; Mannose-6-Phosphate Isomerase; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutation; Peritonitis; Zymosan | 2014 |
The novel benzimidazole derivative BRP-7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5-lipoxygenase-activating protein (FLAP).
Topics: 5-Lipoxygenase-Activating Protein Inhibitors; 5-Lipoxygenase-Activating Proteins; Animals; Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Benzimidazoles; Carrageenan; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Humans; Leukotriene Antagonists; Leukotrienes; Male; Mice; Monocytes; Neutrophils; Peritonitis; Pleurisy; Rats, Wistar; Zymosan | 2014 |
No major role for the transcription factor NF-κB in bone marrow function during peritonitis in the mouse.
Topics: Animals; Bone Marrow; Female; Gene Expression; Genes, Reporter; Lipopolysaccharides; Liver; Luciferases; Lung; Macrophages, Peritoneal; Mice; Mice, Transgenic; Neutrophil Infiltration; Neutrophils; NF-kappa B; Peptones; Peritonitis; Spleen; Zymosan | 2014 |
Vagus nerve controls resolution and pro-resolving mediators of inflammation.
Topics: Animals; Blotting, Western; Cells, Cultured; Chemotaxis; Docosahexaenoic Acids; Humans; Inflammation; Inflammation Mediators; Lipids; Lipoxins; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Fluorescence; Monocytes; Nerve Growth Factors; Netrin-1; Neutrophils; Peritonitis; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Tumor Suppressor Proteins; Vagotomy; Vagus Nerve; Zymosan | 2014 |
The plexin C1 receptor promotes acute inflammation.
Topics: Acute Disease; Animals; Antigens, CD; Inflammation; Mice; Mice, Knockout; Nerve Tissue Proteins; Peritonitis; Receptors, Cell Surface; Semaphorins; Zymosan | 2014 |
In vivo sex differences in leukotriene biosynthesis in zymosan-induced peritonitis.
Topics: Animals; Arachidonate 5-Lipoxygenase; Ascitic Fluid; Capillary Permeability; Female; Leukotriene B4; Leukotriene C4; Macrophages, Peritoneal; Male; Mice; Orchiectomy; Peritonitis; Peroxidase; Sex Characteristics; Testosterone; Zymosan | 2014 |
Mechanisms involved in apoptosis of carp leukocytes upon in vitro and in vivo immunostimulation.
Topics: Analysis of Variance; Animals; Apoptosis; Carps; Fish Diseases; Immunization; Leukocytes; NADPH Oxidases; Peritonitis; Phagocytes; Respiratory Burst; Zymosan | 2014 |
Identification of 14,20-dihydroxy-docosahexaenoic acid as a novel anti-inflammatory metabolite.
Topics: Animals; Animals, Genetically Modified; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, Liquid; Docosahexaenoic Acids; Eosinophils; Lipids; Mass Spectrometry; Mice; Neutrophil Infiltration; Peritonitis; Stereoisomerism; Zymosan | 2014 |
Prevention of neutrophil extravasation by α2-adrenoceptor-mediated endothelial stabilization.
Topics: Adherens Junctions; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Antagonists; Animals; Antigens, CD; beta Catenin; Brimonidine Tartrate; Cadherins; CD11b Antigen; Endothelium, Vascular; gamma Catenin; Humans; Idazoxan; Inflammation; Intercellular Adhesion Molecule-1; L-Selectin; Male; Mice; Neutrophils; Peritonitis; Quinoxalines; Receptors, Adrenergic, alpha-2; Thioglycolates; Transendothelial and Transepithelial Migration; Tumor Necrosis Factor-alpha; Up-Regulation; Xylazine; Zymosan | 2014 |
Aging delays resolution of acute inflammation in mice: reprogramming the host response with novel nano-proresolving medicines.
Topics: Aging; Animals; Aspirin; Autacoids; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Humans; Inflammation; Inflammation Mediators; Leukocytes, Mononuclear; Macrophages; Male; Metabolomics; Mice; Mice, Inbred BALB C; Nanomedicine; Peritonitis; Principal Component Analysis; Zymosan | 2014 |
Methods for assessing the effects of galectins on leukocyte trafficking.
Topics: Animals; Cell Culture Techniques; Cell Movement; Cell Separation; Galectins; Gene Knockout Techniques; Human Umbilical Vein Endothelial Cells; Humans; Image Processing, Computer-Assisted; Leukocytes; Male; Mice; Microscopy; Peritonitis; Zymosan | 2015 |
Role of Serotonin in MODS: Deficiency of Serotonin Protects Against Zymosan-Induced Multiple Organ Failure in Mice.
Topics: 5-Hydroxytryptophan; Animals; Cytokines; Disease Models, Animal; Enzyme Inhibitors; Fenclonine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Multiple Organ Failure; Oxidative Stress; Peritonitis; Protective Agents; Serotonin; Shock; Tryptophan Hydroxylase; Zymosan | 2015 |
[Influence of cholesterol on macrophage foam cells formation at zymosan-induced inflammation of mice].
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Biological Transport; Cholesterol; Foam Cells; Inflammation; Interleukin-10; Liposomes; Male; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Neutrophils; Oleic Acid; Peritonitis; PPAR gamma; Transforming Growth Factor beta; Triglycerides; Tumor Necrosis Factor-alpha; Zymosan | 2014 |
Molecular and cellular profiles of the resolution phase in a damage-associated molecular pattern (DAMP)-mediated peritonitis model and revelation of leukocyte persistence in peritoneal tissues.
Topics: Animals; Apoptosis; B-Lymphocytes; Blotting, Western; Cells, Cultured; Docosahexaenoic Acids; Female; Flow Cytometry; Immunoenzyme Techniques; Inflammation; Leukocytes; Lipids; Macrophages; Mice; Mice, Inbred C57BL; Omentum; Peritonitis; Phagocytosis; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thioglycolates; Zymosan | 2015 |
Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent.
Topics: Animals; Cells, Cultured; Docosahexaenoic Acids; Escherichia coli; Escherichia coli Infections; Esters; Humans; Inflammation; Lung; Macrophages; Mice; Neutrophil Infiltration; Peritonitis; Phagocytes; Phagocytosis; Receptors, G-Protein-Coupled; Reperfusion Injury; Zymosan | 2015 |
Ouabain Modulates Zymosan-Induced Peritonitis in Mice.
Topics: Animals; Cell Survival; Electrophoretic Mobility Shift Assay; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Macrophages; Mice; Ouabain; Peritonitis; Random Allocation; Zymosan | 2015 |
Synthesis and evaluation of the anti-nociceptive and anti-inflammatory activity of 4-aminoquinoline derivatives.
Topics: Aminoquinolines; Analgesics; Animals; Anti-Inflammatory Agents; Arthritis; Freund's Adjuvant; Male; Mice; Pain; Pain Measurement; Peritonitis; Rats; Rats, Wistar; Zymosan | 2015 |
A role for melatonin in maintaining the pro- and anti-inflammatory balance by influencing leukocyte migration and apoptosis in carp.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Carps; Chemokines, CXC; Chemotaxis; Inflammation; Interleukin-12 Subunit p35; Leukocytes; Melatonin; Neutrophil Activation; Neutrophils; Peritonitis; Receptor, Melatonin, MT1; Respiratory Burst; Tumor Necrosis Factor-alpha; Zymosan | 2015 |
Neutrophil contributions to the induction and regulation of the acute inflammatory response in teleost fish.
Topics: Acute Disease; Animals; Apoptosis; Goldfish; Immunity, Innate; Kidney; Leukotriene B4; Lipoxins; Macrophage Activation; Macrophages, Peritoneal; Neutrophils; Peritonitis; Phagocytosis; Reactive Oxygen Species; Respiratory Burst; Time Factors; Zymosan | 2016 |
Anti-Inflammatory Effects of IL-27 in Zymosan-Induced Peritonitis: Inhibition of Neutrophil Recruitment Partially Explained by Impaired Mobilization from Bone Marrow and Reduced Chemokine Levels.
Topics: Animals; Anti-Inflammatory Agents; Bone Marrow; Chemokines; Chemotaxis, Leukocyte; Cytokines; Interleukin-27; Leukocyte Count; Macrophages; Male; Mice; Neutrophils; Peritonitis; Zymosan | 2015 |
HMGB1 Inhibition During Zymosan-Induced Inflammation: The Potential Therapeutic Action of Riboflavin.
Topics: Animals; HMGB1 Protein; Humans; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Peritonitis; Riboflavin; Sepsis; Zymosan | 2016 |
Neutrophil-Expressed p21/waf1 Favors Inflammation Resolution in Pseudomonas aeruginosa Infection.
Topics: Adolescent; Animals; Apoptosis; Cell Count; Cell Differentiation; Cell Line; Cyclin-Dependent Kinase Inhibitor p21; Cystic Fibrosis; Female; Granulocyte Colony-Stimulating Factor; Humans; Lipopolysaccharides; Macrophages; Male; Mice; Models, Biological; Neutrophils; Peritonitis; Phagocytosis; Pneumonia; Proliferating Cell Nuclear Antigen; Pseudomonas aeruginosa; Pseudomonas Infections; RNA, Messenger; Tumor Necrosis Factor-alpha; Zymosan | 2016 |
Novel Pharmacological Properties of Dinoponera quadriceps Giant Ant Venom.
Topics: Animals; Ant Venoms; Anti-Inflammatory Agents; Ants; Carrageenan; Edema; Female; Mice; Peritonitis; Platelet Aggregation; Platelet Aggregation Inhibitors; Zymosan | 2015 |
Dynamic weight bearing as a non-reflexive method for the measurement of abdominal pain in mice.
Topics: Abdominal Pain; Aniline Compounds; Animals; Behavior, Animal; Celecoxib; Chronic Pain; Cyclooxygenase 2 Inhibitors; Dinoprostone; Disease Models, Animal; Furans; Inflammation; Mice; Pain Measurement; Pelvic Pain; Peritoneal Lavage; Peritonitis; Sodium Channel Blockers; Weight-Bearing; Zymosan | 2016 |
Attenuation of the programmed cell death-1 pathway increases the M1 polarization of macrophages induced by zymosan.
Topics: Animals; Apoptosis; B7-H1 Antigen; Cell Polarity; Chemokine CCL2; Cytokines; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peritonitis; Programmed Cell Death 1 Ligand 2 Protein; Programmed Cell Death 1 Receptor; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Signal Transduction; STAT1 Transcription Factor; STAT6 Transcription Factor; Transcription Factor RelA; Zymosan | 2016 |
Interfering with the CCL2-glycosaminoglycan axis as a potential approach to modulate neuroinflammation.
Topics: Animals; Anti-Inflammatory Agents; Cerebellum; Chemokine CCL2; Dexamethasone; Disease Models, Animal; Encephalitis; Encephalomyelitis, Autoimmune, Experimental; Female; Glycosaminoglycans; Inhibitory Concentration 50; Male; Mice; Mice, Inbred C57BL; Monocytes; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Peritonitis; Spinal Cord; Zymosan | 2016 |
Application of imaging flow cytometry for characterization of acute inflammation in non-classical animal model systems.
Topics: Acute Disease; Animals; Anthraquinones; Apoptosis; Bone Marrow Cells; Chickens; Coloring Agents; Flow Cytometry; Image Cytometry; Injections, Intraperitoneal; Leukocyte Count; Leukocytes; Peritoneum; Peritonitis; Rosaniline Dyes; Staining and Labeling; Tetradecanoylphorbol Acetate; Zymosan | 2017 |
Zymosan-Induced Peritonitis: Effects on Cardiac Function, Temperature Regulation, Translocation of Bacteria, and Role of Dectin-1.
Topics: Alarmins; Animals; Disease Models, Animal; Inflammation; Lectins, C-Type; Male; Mice; Mice, Knockout; Multiple Organ Failure; Peritonitis; Receptors, Pattern Recognition; Zymosan | 2016 |
Proton pump inhibitors protect mice from acute systemic inflammation and induce long-term cross-tolerance.
Topics: Animals; Cryopyrin-Associated Periodic Syndromes; Esomeprazole; Gene Expression Regulation; Humans; Interleukin-1beta; Lipopolysaccharides; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Monocytes; Omeprazole; Peritonitis; Primary Cell Culture; Proton Pump Inhibitors; Shock, Septic; Signal Transduction; Survival Analysis; Thioglycolates; Toll-Like Receptors; Tumor Necrosis Factor-alpha; Zymosan | 2016 |
Aqueous extract from Ipomoea asarifolia (Convolvulaceae) leaves and its phenolic compounds have anti-inflammatory activity in murine models of edema, peritonitis and air-pouch inflammation.
Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Chemotaxis, Leukocyte; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Female; Inflammation; Inflammation Mediators; Ipomoea; Leukocyte Count; Leukocytes; Male; Mass Spectrometry; Mice, Inbred BALB C; Peritonitis; Phenols; Phytotherapy; Plant Extracts; Plant Leaves; Plants, Medicinal; Time Factors; Xylenes; Zymosan | 2016 |
PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.
Topics: Animals; Cecum; Cell Polarity; Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit; Disease Models, Animal; Female; Gene Deletion; Hydantoins; Inflammation; Janus Kinase 2; Ligation; Macrophages; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Ischemia; Peritonitis; Prostaglandin D2; Protein Binding; Protein Subunits; Punctures; Receptors, Immunologic; Receptors, Interferon; Receptors, Prostaglandin; Signal Transduction; STAT1 Transcription Factor; Wound Healing; Zymosan | 2016 |
Galectin-3-null mice display defective neutrophil clearance during acute inflammation.
Topics: Acute Disease; Animals; Apoptosis; Cell Membrane; Cytosol; Disease Models, Animal; Galectin 3; Inflammation; Male; Mice, Inbred C57BL; Neutrophils; Peritonitis; Zymosan | 2017 |
Effect of patchouli (Pogostemon cablin) essential oil on in vitro and in vivo leukocytes behavior in acute inflammatory response.
Topics: Acute Disease; Administration, Topical; Animals; Cell Adhesion; Cell Survival; Chemotaxis; Edema; Exudates and Transudates; Gas Chromatography-Mass Spectrometry; Inflammation; Leukocyte Count; Leukocyte Rolling; Leukocytes; Male; Mice; Nitric Oxide; Peritonitis; Peroxidase; Phagocytosis; Pogostemon; Sesquiterpenes; Zymosan | 2016 |
Role of lymphocytes in the course of murine zymosan-induced peritonitis.
Topics: Animals; Capillary Permeability; Chemokines; Cytokines; Dinoprostone; Homeodomain Proteins; Lymphocytes; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Peritonitis; Protein Array Analysis; Zymosan | 2008 |
Expression profiles of matrix metalloproteinase 9 in teleost fish provide evidence for its active role in initiation and resolution of inflammation.
Topics: Animals; Base Sequence; Carps; Cells, Cultured; DNA Primers; Electrophoresis, Polyacrylamide Gel; Gene Expression; Immunity, Innate; Kidney; Matrix Metalloproteinase 9; Molecular Sequence Data; Peritonitis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spleen; Thymus Gland; Zymosan | 2008 |
Fumonisin b1 reduces the development of multiple organ failure induced by zymosan in mice.
Topics: Animals; Cytokines; Fumonisins; Immunohistochemistry; Inflammation; Male; Mice; Multiple Organ Failure; Nitric Oxide; Peritonitis; Peroxidase; Shock; Time Factors; Treatment Outcome; Zymosan | 2009 |
Morphine affects the inflammatory response in carp by impairment of leukocyte migration.
Topics: Animals; Apoptosis; Carps; Cells, Cultured; Chemokines; Chemotaxis, Leukocyte; Cytokines; Immunity, Innate; Leukocytes; Ligands; Morphine; Nitric Oxide; Peritonitis; Phagocytes; Receptors, Opioid, mu; Respiratory Burst; Zymosan | 2009 |
Possible mechanism of the anti-inflammatory activity of ruscogenin: role of intercellular adhesion molecule-1 and nuclear factor-kappaB.
Topics: Active Transport, Cell Nucleus; Animals; Anti-Inflammatory Agents; Cell Line; Cell Movement; Dinoprostone; Disease Models, Animal; DNA; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Intercellular Adhesion Molecule-1; Leukocytes; Male; Mice; Mice, Inbred ICR; Ophiopogon; Peritonitis; Plant Tubers; RNA, Messenger; Spirostans; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Zymosan | 2008 |
Strain-specific differences in modulatory effects of morphine on peritoneal inflammation in mice.
Topics: Animals; Dose-Response Relationship, Drug; Leukocytes; Male; Mice; Mice, Inbred Strains; Morphine; Naltrexone; Peritonitis; Zymosan | 2005 |
Effects of macrophage depletion on peritoneal inflammation in swiss mice, edible frogs and goldfish.
Topics: Analgesics, Opioid; Animals; Clodronic Acid; Goldfish; Macrophages, Peritoneal; Mice; Morphine; Neutrophils; Peritonitis; Ranidae; Zymosan | 2004 |
Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Autacoids; Cell Movement; Dinoprostone; Docosahexaenoic Acids; Eicosapentaenoic Acid; Humans; Inflammation Mediators; Leukocytes, Mononuclear; Lipid Metabolism; Lipoxygenase; Macrophages; Macrophages, Peritoneal; Mice; Mice, Inbred Strains; Molecular Structure; Neutrophils; Peritonitis; Phagocytosis; Stereoisomerism; Zymosan | 2009 |
Increased cyclooxygenase activity impairs apoptosis of inflammatory neutrophils in mice lacking gelatinase B/matrix metalloproteinase-9.
Topics: Animals; Apoptosis; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Male; Matrix Metalloproteinase 9; Membrane Proteins; Mice; Mice, Knockout; Neutrophil Infiltration; Neutrophils; Peritonitis; Prostaglandin D2; Pyrazoles; Thiophenes; Zymosan | 2009 |
Effects of nitric oxide on neutrophil influx depends on the tissue: role of leukotriene B4 and adhesion molecules.
Topics: Acute Disease; Animals; Arthritis; CD18 Antigens; Cell Movement; Intercellular Adhesion Molecule-1; Interleukin-10; Joints; Leukotriene B4; Lipopolysaccharides; Male; Mice; Mice, Knockout; Neutrophil Infiltration; Nitric Oxide; Nitric Oxide Synthase; Peritoneal Cavity; Peritonitis; Rats; Rats, Wistar; Species Specificity; Tumor Necrosis Factor-alpha; Zymosan | 2009 |
In vitro and in vivo characterization of A-940894: a potent histamine H4 receptor antagonist with anti-inflammatory properties.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Binding, Competitive; Calcium; Cell Shape; Chemotaxis; Eosinophils; Female; Histamine; Humans; Male; Mast Cells; Mice; Mice, Inbred BALB C; Peritonitis; Piperazines; Prostaglandin D2; Pyrimidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Recombinant Proteins; RNA, Messenger; Zymosan | 2009 |
Transcellular biosynthesis of cysteinyl leukotrienes in vivo during mouse peritoneal inflammation.
Topics: Animals; Arachidonate 5-Lipoxygenase; Bone Marrow; Bone Marrow Transplantation; Cell Communication; Cysteine; Enzymes; Inflammation; Inflammation Mediators; Leukotrienes; Metabolic Networks and Pathways; Mice; Mice, Transgenic; Peritonitis; Zymosan | 2009 |
Chapter 17. Zymosan-induced peritonitis as a simple experimental system for the study of inflammation.
Topics: Animals; Disease Models, Animal; Inflammation; Mice; Peritonitis; Rats; Zymosan | 2009 |
Zymosan, but not lipopolysaccharide, triggers severe and progressive peritoneal injury accompanied by complement activation in a rat peritonitis model.
Topics: Animals; Cell Movement; Complement Activation; Complement C3b; Complement Membrane Attack Complex; Disease Models, Animal; Lipopolysaccharides; Male; Neovascularization, Pathologic; Peritoneum; Peritonitis; Rats; Rats, Sprague-Dawley; Yeasts; Zymosan | 2009 |
Total synthesis and bioactivity of resolvin E2.
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Eicosapentaenoic Acid; Mice; Neutrophil Infiltration; Peritonitis; Stereoisomerism; Zymosan | 2009 |
Monocyte chemoattractant protein-1 (MCP-1), not MCP-3, is the primary chemokine required for monocyte recruitment in mouse peritonitis induced with thioglycollate or zymosan A.
Topics: Animals; Carboxypeptidases A; Cell Movement; Chemokine CCL2; Disease Models, Animal; Down-Regulation; Gene Deletion; Lipopolysaccharides; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Peritonitis; Thioglycolates; Up-Regulation; Zymosan | 2009 |
Inflammatory macrophages, and not only neutrophils, die by apoptosis during acute peritonitis.
Topics: Animals; Apoptosis; Caspases; Macrophages, Peritoneal; Mice; Neutrophils; Nitric Oxide; Peritoneum; Peritonitis; Proto-Oncogene Proteins c-bcl-2; Time Factors; Tumor Necrosis Factor-alpha; Zymosan | 2010 |
Altered apoptosis of inflammatory neutrophils in MMP-9-deficient mice is due to lower expression and activity of caspase-3.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 8; Caspase 9; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Female; Flow Cytometry; Gene Expression Regulation, Enzymologic; Immunohistochemistry; Inflammation; Male; Matrix Metalloproteinase 9; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Fluorescence; Neutrophils; Peritonitis; Proto-Oncogene Proteins c-bcl-2; Pyrazoles; Reverse Transcriptase Polymerase Chain Reaction; Zymosan | 2009 |
[Effect of TSP-2 antibody against a single epitope of mouse Toll-like receptor 2 extracellular domain on zymosan A-induced peritonitis in mice].
Topics: Animals; Antibodies; Behavior, Animal; Epitopes; Extracellular Space; Female; Leukocyte Count; Mast Cells; Mice; Peritoneal Lavage; Peritonitis; Protein Structure, Tertiary; Toll-Like Receptor 2; Zymosan | 2009 |
Enhanced production of IL-17A during zymosan-induced peritonitis in obese mice.
Topics: Acute Disease; Animals; Ascitic Fluid; Chemokines, CXC; Dietary Fats; Female; Gene Expression Regulation; Inflammation; Interleukin-17; Interleukin-6; Intra-Abdominal Fat; Leptin; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Neutrophils; Obesity; Peritonitis; T-Lymphocyte Subsets; Thinness; Zymosan | 2010 |
PD98059, a specific MAP kinase inhibitor, attenuates multiple organ dysfunction syndrome/failure (MODS) induced by zymosan in mice.
Topics: Acute Disease; Animals; Apoptosis; bcl-2-Associated X Protein; Cell Adhesion Molecules; Cytokines; Fas Ligand Protein; Flavonoids; I-kappa B Proteins; Inflammation Mediators; Male; Mice; Mitogen-Activated Protein Kinases; Multiple Organ Failure; Neutrophil Infiltration; NF-KappaB Inhibitor alpha; Nitric Oxide; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Peritonitis; Phosphorylation; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Systemic Inflammatory Response Syndrome; Time Factors; Transcription Factor RelA; Tyrosine; Zymosan | 2010 |
Selenoproteins regulate macrophage invasiveness and extracellular matrix-related gene expression.
Topics: Animals; Cell Movement; Cytokines; Dermatitis, Irritant; Extracellular Matrix Proteins; Fibroblasts; Gene Expression Profiling; Gene Expression Regulation; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; NIH 3T3 Cells; Oxidation-Reduction; Peritonitis; Phorbol Esters; RNA, Transfer; Selenoproteins; Zymosan | 2009 |
Uncoupling protein-2 negatively regulates polymorphonuclear leukocytes chemotaxis via modulating [Ca2+] influx.
Topics: Animals; Calcium; CD11b Antigen; CD18 Antigens; Cell Movement; Chemotaxis; Cytoplasm; Diabetes Mellitus, Experimental; Disease Models, Animal; Ion Channels; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondrial Proteins; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Peritonitis; Streptozocin; Uncoupling Protein 2; Zymosan | 2010 |
A new strategy for the identification of novel molecules with targeted proresolution of inflammation properties.
Topics: Animals; Cell Movement; Cells, Cultured; Drug Delivery Systems; Homeostasis; Inflammation Mediators; Injections, Intraperitoneal; Lymphocytes; Macrophages; Mice; Mice, Inbred C57BL; Neutrophils; Peritonitis; Zymosan | 2010 |
Editorial: acute inflammation in obesity: IL-17A in the middle of the battle.
Topics: Acute Disease; Adipose Tissue; Animals; CD4-Positive T-Lymphocytes; Diet; Female; Humans; Immunity, Innate; Inflammation; Interleukin-17; Leptin; Mice; Mice, Obese; Neutrophils; Obesity; Peritonitis; Zymosan | 2010 |
Intravital imaging of IL-1beta production in skin.
Topics: Animals; Arthritis; Cells, Cultured; Dermatitis, Contact; Disease Models, Animal; Interleukin-1beta; Lipopolysaccharides; Luminescent Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Confocal; Oxazolone; Peritonitis; Skin; Zymosan | 2010 |
CFTR inhibition provokes an inflammatory response associated with an imbalance of the annexin A1 pathway.
Topics: Animals; Annexin A1; Benzoates; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Inflammation; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophils; Peritonitis; Thiazolidines; Zymosan | 2010 |
Oral administration of 2-docosahexaenoyl lysophosphatidylcholine displayed anti-inflammatory effects on zymosan A-induced peritonitis.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 15-Lipoxygenase; Cell Line; Cell Survival; Dinoprostone; Docosahexaenoic Acids; Humans; Kinetics; Leukotriene C4; Lysophosphatidylcholines; Male; Mice; Mice, Inbred ICR; Nitric Oxide; Oxidation-Reduction; Peritonitis; Substrate Specificity; Zymosan | 2011 |
Circulating platelet-neutrophil complexes are important for subsequent neutrophil activation and migration.
Topics: Adult; Animals; Blood Platelets; Bronchoalveolar Lavage Fluid; Busulfan; CD18 Antigens; Cells, Cultured; Chemokine CCL17; Chemokine CCL22; Chemotaxis, Leukocyte; Disease Models, Animal; Female; Humans; Lipopolysaccharides; Male; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Middle Aged; Neutrophil Activation; Neutrophil Infiltration; Neutrophils; P-Selectin; Peritonitis; Platelet Adhesiveness; Pneumonia; Thrombocytopenia; Young Adult; Zymosan | 2010 |
Synthesis and pharmacological evaluation of pyrazine N-acylhydrazone derivatives designed as novel analgesic and anti-inflammatory drug candidates.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Arthritis; Ear; Edema; Female; Freund's Adjuvant; Hydrazones; Male; Mice; Pain; Peritonitis; Pyrazines; Rats; Rats, Wistar; Zymosan | 2010 |
Protective effect of chloral hydrate against lipopolysaccharide/D-galactosamine-induced acute lethal liver injury and zymosan-induced peritonitis in mice.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Chemical and Drug Induced Liver Injury; Chloral Hydrate; Cyclooxygenase 2; Cytokines; Cytoprotection; Dinoprostone; Galactosamine; Inflammation Mediators; Lipopolysaccharides; Mice; Mice, Inbred BALB C; NF-kappa B; Nitric Oxide Synthase Type II; Peritonitis; Zymosan | 2010 |
A distinct subset of podoplanin (gp38) expressing F4/80+ macrophages mediate phagocytosis and are induced following zymosan peritonitis.
Topics: Animals; Fibroblasts; Macrophages; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Peritonitis; Phagocytes; Phagocytosis; Zymosan | 2010 |
PPARγ activation normalizes resolution of acute sterile inflammation in murine chronic granulomatous disease.
Topics: Animals; Cytokines; Gene Deletion; Gene Expression Regulation; Granulomatous Disease, Chronic; Humans; Inflammation; Macrophages; Male; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; NADPH Oxidase 2; NADPH Oxidases; Neutrophils; Peritonitis; Pioglitazone; PPAR gamma; Thiazolidinediones; Zymosan | 2010 |
MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits.
Topics: Acute Disease; Animals; Docosahexaenoic Acids; Gene Expression Regulation; Inflammation; Mice; MicroRNAs; Peritonitis; Polymerase Chain Reaction; Recombinant Proteins; Zymosan | 2011 |
Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice.
Topics: Animals; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Docosahexaenoic Acids; Eosinophils; Inflammation; Male; Mice; Mice, Inbred C57BL; Peritonitis; Time Factors; Zymosan | 2011 |
Mechanisms for anti-inflammatory effects of 1-[15(S)-hydroxyeicosapentaenoyl] lysophosphatidylcholine, administered intraperitoneally, in zymosan A-induced peritonitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Eicosapentaenoic Acid; In Vitro Techniques; Inflammation Mediators; Injections, Intraperitoneal; Leukocytes; Leukotriene B4; Leukotriene C4; Lysophosphatidylcholines; Male; Mice; Mice, Inbred ICR; Oligopeptides; Oxidation-Reduction; Peritonitis; Structure-Activity Relationship; Zymosan | 2011 |
Strain-specific effects of riboflavin supplementation on zymosan-induced peritonitis in C57BL/6J, BALB/c and CBA mice.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Gene Expression Regulation; Injections, Intraperitoneal; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred CBA; Peritonitis; Riboflavin; Species Specificity; Zymosan | 2011 |
Novel macrophage polarization model: from gene expression to identification of new anti-inflammatory molecules.
Topics: Adenosine Triphosphate; Animals; Blotting, Western; Cytokines; Diphosphates; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Macrophage Activation; Male; Mice; Mice, Inbred C57BL; Models, Biological; Peritonitis; Reverse Transcriptase Polymerase Chain Reaction; Toll-Like Receptors; Zymosan | 2011 |
Peritoneal resorption capacity for lipopolysaccharide and interleukin-6 in acute zymosan-induced chemical peritonitis.
Topics: Animals; Inflammation Mediators; Interleukin-6; Lipopolysaccharides; Male; Peritoneum; Peritonitis; Rats; Rats, Wistar; Zymosan | 2011 |
Repulsive guidance molecule-A (RGM-A) inhibits leukocyte migration and mitigates inflammation.
Topics: Animals; Caco-2 Cells; Chemotaxis; Cytokines; Epithelium; Gene Expression Regulation; GPI-Linked Proteins; Humans; Inflammation; Leukocytes; Mice; Mice, Knockout; Nerve Tissue Proteins; Organ Specificity; Peritonitis; Zymosan | 2011 |
Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages.
Topics: Animals; Anti-Inflammatory Agents; Cell Adhesion Molecules; Cells, Cultured; Down-Regulation; Drug Evaluation, Preclinical; Humans; Macrophages, Peritoneal; Male; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Mice, Transgenic; NF-kappa B; Peritonitis; RNA, Small Interfering; Signal Transduction; Toll-Like Receptor 2; Zymosan | 2011 |
Total synthesis and bioactivity of 18(R)-hydroxyeicosapentaenoic acid.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Eicosapentaenoic Acid; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Neutrophil Infiltration; Peritonitis; Stereoisomerism; Zymosan | 2011 |
2-Polyunsaturated acyl lysophosphatidylethanolamine attenuates inflammatory response in zymosan A-induced peritonitis in mice.
Topics: Animals; Anti-Inflammatory Agents; Arachidonate 15-Lipoxygenase; Cytokines; Leukocytes; Lipoxygenase Inhibitors; Lysophospholipids; Mice; Mice, Inbred ICR; Oxidation-Reduction; Peritonitis; Zymosan | 2011 |
Analgesic and anti-inflammatory activities of salicylaldehyde 2-chlorobenzoyl hydrazone (H(2)LASSBio-466), salicylaldehyde 4-chlorobenzoyl hydrazone (H(2)LASSBio-1064) and their zinc(II) complexes.
Topics: Acetic Acid; Aldehydes; Analgesics; Animals; Anti-Inflammatory Agents; Coordination Complexes; Crystallography, X-Ray; Dipyrone; Female; Formaldehyde; Hot Temperature; Hydrazones; Indomethacin; Inflammation; Magnetic Resonance Spectroscopy; Male; Mice; Morphine; Pain; Pain Measurement; Peritonitis; Zinc; Zymosan | 2011 |
Aqueous and Methanolic Extracts of
Topics: Animals; Anti-Inflammatory Agents; Caulerpa; Cell Movement; Cells, Cultured; Chlorophyta; Cytokines; Ear; Edema; Macrophages; Male; Methanol; Mice; Mice, Inbred BALB C; Peritonitis; Phytotherapy; Plant Extracts; Water; Xylenes; Zymosan | 2011 |
Human CD16+ and CD16- monocyte subsets display unique effector properties in inflammatory conditions in vivo.
Topics: Adoptive Transfer; Animals; GPI-Linked Proteins; Humans; Immunity, Innate; Inflammation; Inflammation Mediators; Lipopolysaccharides; Mice; Mice, SCID; Monocytes; Peritonitis; Receptors, IgG; Zymosan | 2011 |
Transcriptomic analyses of murine resolution-phase macrophages.
Topics: Animals; Bone Marrow Cells; Cells, Cultured; Female; Flow Cytometry; Gene Expression Profiling; Macrophages; Male; Mice; Mice, Inbred C57BL; Oligonucleotide Array Sequence Analysis; Peritonitis; Reverse Transcriptase Polymerase Chain Reaction; Transcriptome; Zymosan | 2011 |
Regulation of the inflammatory response: enhancing neutrophil infiltration under chronic inflammatory conditions.
Topics: Acute Disease; Animals; Chronic Disease; Colitis; Disease Models, Animal; Feedback, Physiological; Inflammation; Inflammation Mediators; Interleukin-17; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Neutrophils; Peritonitis; Zymosan | 2012 |
Morphine-modulated mast cell migration and proliferation during early stages of zymosan-induced peritonitis in CBA mice.
Topics: Animals; Cell Movement; Cell Proliferation; Male; Mast Cells; Mice; Mice, Inbred CBA; Morphine; Peritonitis; Zymosan | 2011 |
Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acid.
Topics: Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Docosahexaenoic Acids; Eosinophils; Female; HEK293 Cells; Humans; Inflammation Mediators; Magnetic Resonance Spectroscopy; Male; Molecular Structure; Neutrophils; Peritonitis; Zymosan | 2012 |
Membrane complement regulators protect against fibrin exudation increases in a severe peritoneal inflammation model in rats.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Antigens, Surface; CD59 Antigens; Complement Activation; Complement System Proteins; Disease Models, Animal; Fibrin; Homeostasis; Male; Peritoneal Dialysis; Peritoneum; Peritonitis; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Severity of Illness Index; Zymosan | 2012 |
Diversification of IFNγ-inducible CXCb chemokines in cyprinid fish.
Topics: Animals; Carps; Chemokines, CXC; Cloning, Molecular; Evolution, Molecular; Interferon-gamma; Leukocytes; Lipopolysaccharides; Peritoneum; Peritonitis; Promoter Regions, Genetic; Transcriptome; Zebrafish; Zymosan | 2012 |
Synthesis, acute toxicity and anti-inflammatory effect of bornyl salicylate, a salicylic acid derivative.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Carrageenan; Cell Movement; Cytokines; Dinoprostone; Drug Evaluation, Preclinical; Eating; Female; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Neutrophils; Nitric Oxide; Oxytocics; Peritonitis; Salicylates; Vasodilator Agents; Zymosan | 2012 |
Self-limited versus delayed resolution of acute inflammation: temporal regulation of pro-resolving mediators and microRNA.
Topics: 3' Untranslated Regions; Acute Disease; Animals; Apoptosis; Arachidonate 5-Lipoxygenase; Cells, Cultured; Dinoprostone; Exudates and Transudates; Gene Expression; Humans; Inflammation; Inflammation Mediators; Leukotriene B4; Lipid Metabolism; Macrophages; Male; Mice; MicroRNAs; Neutrophils; Peritonitis; Prostaglandin D2; RNA Interference; Zymosan | 2012 |
Antinociceptive and anti-inflammatory activities of crude methanolic extract of red alga Bryothamnion triquetrum.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Dipyrone; Female; Indomethacin; Leukocytes; Male; Methanol; Mice; Morphine; Pain; Peritonitis; Plant Extracts; Rhodophyta; Zymosan | 2012 |
Modulation of zymosan-induced peritonitis by riboflavin co-injection, pre-injection or post-injection in male Swiss mice.
Topics: Animals; Apoptosis; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Inflammation; Inflammation Mediators; Injections, Intraperitoneal; Male; Matrix Metalloproteinase 9; Mice; Neutrophils; Nitric Oxide; Nociception; Peritonitis; Riboflavin; Time Factors; Zymosan | 2012 |
A soluble form of the CSF-1 receptor contributes to the inhibition of inflammation in a teleost fish.
Topics: Animals; Apoptosis; Cells, Cultured; Fish Diseases; Fish Proteins; Goldfish; Inflammation; Inflammation Mediators; Kidney; Macrophages; Peritoneal Cavity; Peritonitis; Receptor, Macrophage Colony-Stimulating Factor; Zymosan | 2013 |
Effects of calpain inhibitor I on multiple organ failure induced by zymosan in the rat.
Topics: Animals; Calpain; Cell Movement; Cyclooxygenase 2; Dose-Response Relationship, Drug; Glycoproteins; Immunohistochemistry; Intestinal Mucosa; Intestines; Isoenzymes; Liver; Lung; Male; Malondialdehyde; Multiple Organ Failure; Neutrophils; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peritoneum; Peritonitis; Peroxidase; Peroxynitrous Acid; Poly Adenosine Diphosphate Ribose; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Tyrosine; Zymosan | 2002 |
Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense.
Topics: 3T3 Cells; Animals; Cell Line; Chromatography, Liquid; Dinoprostone; Female; Humans; Hydroxyeicosatetraenoic Acids; Inflammation; Leukotriene B4; Lipoxins; Male; Mass Spectrometry; Mice; Mice, Transgenic; Neutrophil Infiltration; NF-kappa B; Peritoneum; Peritonitis; Plasmids; Receptors, Cell Surface; Receptors, Formyl Peptide; Receptors, Lipoxin; Skin; Transfection; Tumor Necrosis Factor-alpha; Zymosan | 2003 |
Platelet-activating factor acetylhydrolase inhibits alveolar macrophage activation in vivo.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Cells, Cultured; Cytokines; Lung; Lung Injury; Macrophage Activation; Macrophages, Alveolar; Male; Mitogen-Activated Protein Kinases; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Peritonitis; Phospholipases A; Pneumonia; Rats; Rats, Wistar; Zymosan | 2003 |
Host-adapted Borrelia burgdorferi in mice expresses OspA during inflammation.
Topics: Adaptation, Physiological; Animals; Antigens, Surface; Bacterial Outer Membrane Proteins; Bacterial Vaccines; Borrelia burgdorferi; Cell Count; Cytokines; Female; Flow Cytometry; Gene Expression Regulation, Bacterial; Lipoproteins; Mice; Peritonitis; Transcription, Genetic; Zymosan | 2003 |
Myeloperoxidase response to peritonitis in an experimental model.
Topics: Animals; Male; Neutrophils; Peritonitis; Peroxidase; Random Allocation; Rats; Rats, Wistar; Zymosan | 2003 |
Zymosan induces nitric oxide production by peritoneal mesothelial cells.
Topics: Animals; Cell Culture Techniques; Disease Models, Animal; Epithelial Cells; Male; Nitric Oxide; Peritoneal Cavity; Peritonitis; Random Allocation; Rats; Rats, Wistar; Zymosan | 2004 |
Treatment with a novel poly(ADP-ribose) glycohydrolase inhibitor reduces development of septic shock-like syndrome induced by zymosan in mice.
Topics: Acute Disease; Amides; Animals; Glycoside Hydrolases; Interleukin-1; Male; Malondialdehyde; Mice; Mice, Inbred Strains; Multiple Organ Failure; Peritonitis; Peroxidase; Shock, Septic; Tannins; Tumor Necrosis Factor-alpha; Zymosan | 2004 |
Tissue- and time-dependent upregulation of cytokine mRNA in a murine model for the multiple organ dysfunction syndrome.
Topics: Animals; Cytokines; Escherichia coli; Interferon-gamma; Interleukins; Kidney; Lipopolysaccharides; Liver; Lung; Mice; Mice, Inbred C57BL; Multiple Organ Failure; Peritonitis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spleen; Time Factors; Tumor Necrosis Factor-alpha; Up-Regulation; Zymosan | 2004 |
Methylguanidine reduces the development of non septic shock induced by zymosan in mice.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Exudates and Transudates; Immunohistochemistry; Intestinal Mucosa; Intestines; Kidney; Lipid Peroxidation; Lung; Male; Methylguanidine; Mice; Neutrophils; Pancreas; Peritonitis; Peroxidase; Peroxynitrous Acid; Poly(ADP-ribose) Polymerases; Shock; Tyrosine; Zymosan | 2004 |
Role of 5-lipoxygenase in the multiple organ failure induced by zymosan.
Topics: Animals; Arachidonate 5-Lipoxygenase; Lipid Peroxidation; Male; Mice; Mice, Knockout; Models, Animal; Multiple Organ Failure; Nitric Oxide; Peritonitis; Random Allocation; Syndrome; Zymosan | 2004 |
Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration.
Topics: Administration, Oral; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Ear, External; Inflammation; Injections, Intravenous; Lipoxins; Lung Diseases; Male; Mice; Peritonitis; Reperfusion Injury; Zymosan | 2004 |
Peritoneal mesothelial cells produce inflammatory related cytokines.
Topics: Animals; Blotting, Western; Cells, Cultured; Cytokines; Inflammation Mediators; Interleukin-1; Interleukin-10; Interleukin-6; Lipopolysaccharides; Male; Peritoneum; Peritonitis; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor-alpha; Zymosan | 2004 |
Mast cells are responsible for the lack of anti-inflammatory effects of morphine in CBA mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Degranulation; Histamine Release; In Vitro Techniques; Inflammation Mediators; Male; Mast Cells; Mice; Mice, Inbred CBA; Morphine; p-Methoxy-N-methylphenethylamine; Peritonitis; Species Specificity; Zymosan | 2004 |
Altered chemokine response in an animal model of multiple organ dysfunction syndrome induced by zymosan.
Topics: Animals; Ascitic Fluid; Bronchoalveolar Lavage Fluid; Chemokine CCL2; Chemokines; Disease Models, Animal; Injections, Intraperitoneal; Male; Multiple Organ Failure; Peritonitis; Random Allocation; Rats; Rats, Sprague-Dawley; Zymosan | 2005 |
Morphine-induced changes in the activity of proopiomelanocortin and prodynorphin systems in zymosan-induced peritonitis in mice.
Topics: Animals; Cell Proliferation; Enkephalins; Leukocytes; Male; Mice; Morphine; Peritonitis; Pro-Opiomelanocortin; Protein Precursors; Receptors, Opioid, kappa; Receptors, Opioid, mu; RNA, Messenger; Zymosan | 2005 |
Dietary supplementation with n-3 polyunsaturated fatty acids attenuates the depression of food-motivated behavior during zymosan-induced peritonitis.
Topics: Animals; Dietary Supplements; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Feeding Behavior; Mice; Motivation; Peritonitis; Triglycerides; Zymosan | 2005 |
Met-enkephalin involvement in morphine-modulated peritonitis in swiss mice.
Topics: Analgesics, Opioid; Animals; Enkephalin, Methionine; Leukocytes; Male; Mice; Morphine; Peritonitis; Zymosan | 2005 |
Novel polyisoprenyl phosphates block phospholipase D and human neutrophil activation in vitro and murine peritoneal inflammation in vivo.
Topics: Animals; Computer Simulation; Humans; In Vitro Techniques; Male; Mice; Mice, Inbred Strains; Models, Molecular; Neutrophil Activation; Neutrophils; Peritonitis; Phospholipase D; Polyisoprenyl Phosphates; Reactive Oxygen Species; Structure-Activity Relationship; Zymosan | 2005 |
The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering.
Topics: Animals; Apoptosis; Arachidonate 15-Lipoxygenase; Brain; Chromatography, Liquid; Cytokines; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Humans; In Situ Nick-End Labeling; Inflammation; Interferon-gamma; Leukocytes, Mononuclear; Male; Mass Spectrometry; Membrane Microdomains; Mice; Models, Chemical; Oxidative Stress; Peritonitis; T-Lymphocytes; Time Factors; Tumor Necrosis Factor-alpha; Zymosan | 2005 |
The melanocortin peptide HP228 displays protective effects in acute models of inflammation and organ damage.
Topics: Acute Disease; alpha-MSH; Animals; Anti-Inflammatory Agents; Blood Pressure; Carrageenan; Chemokine CXCL1; Chemokines; Chemokines, CXC; Cyclic AMP; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rate; Inflammation; Interleukin-1; Macrophages, Peritoneal; Male; Mice; Myocardial Reperfusion Injury; Oligopeptides; Peritonitis; Time Factors; Tumor Necrosis Factor-alpha; Uric Acid; Zymosan | 2006 |
The effects of oral Cardax (disodium disuccinate astaxanthin) on multiple independent oxidative stress markers in a mouse peritoneal inflammation model: influence on 5-lipoxygenase in vitro and in vivo.
Topics: Animals; Arachidonate 5-Lipoxygenase; Biomarkers; Chromatography, High Pressure Liquid; Circular Dichroism; Crystallography, X-Ray; Inflammation; Mice; Mice, Inbred C57BL; Models, Molecular; Neutrophil Infiltration; Oxidative Stress; Peritonitis; Pharmaceutical Vehicles; Succinates; Xanthophylls; Zymosan | 2006 |
Gelatinase B/matrix metalloproteinase-9 contributes to cellular infiltration in a murine model of zymosan peritonitis.
Topics: Animals; Cell Movement; Chemokines; Disease Models, Animal; Enzyme Precursors; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Neutrophils; Peritonitis; Recombinant Proteins; Tissue Inhibitor of Metalloproteinase-1; Zymosan | 2006 |
Pharmacological profile of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on acute and chronic inflammation models.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acute Disease; Animals; Anti-Inflammatory Agents; Carrageenan; Chronic Disease; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phosphodiesterases, Type 7; Cyclosporine; Dermatitis, Contact; Edema; Erythrocytes; Fumarates; Hypersensitivity, Delayed; Immunosuppressive Agents; Indoles; Inflammation; Male; Mice; Mice, Inbred BALB C; Peritonitis; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Sheep; Sulfonamides; Toluene 2,4-Diisocyanate; Zymosan | 2006 |
Anti-inflammatory effects of a novel peptide designed to bind with NF-kappaB p50 subunit.
Topics: Animals; Anti-Inflammatory Agents; Binding Sites; Biosensing Techniques; Cell Line, Tumor; Edema; Humans; Interleukin-6; Leukemia, Monocytic, Acute; Mice; Mice, Inbred BALB C; NF-kappa B p50 Subunit; Peptides; Peritonitis; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; Zymosan | 2006 |
Chronic hyperglycemia predisposes to exaggerated inflammatory response and leukocyte dysfunction in Akita mice.
Topics: Acute Disease; Animals; Chemotaxis, Leukocyte; Chronic Disease; Cytokines; Female; Hyperglycemia; Inflammation; Leukocytes; Male; Mice; Mice, Mutant Strains; Neutrophils; Peritonitis; Point Mutation; Superoxides; Zymosan | 2006 |
Resolvin E2: identification and anti-inflammatory actions: pivotal role of human 5-lipoxygenase in resolvin E series biosynthesis.
Topics: Animals; Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Disease Models, Animal; Eicosapentaenoic Acid; Humans; Mice; Neutrophils; Peritonitis; Zymosan | 2006 |
Anti-inflammatory effects of taurine derivatives (taurine chloramine, taurine bromamine, and taurolidine) are mediated by different mechanisms.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Chloramines; Enzyme Induction; Heme Oxygenase-1; Inflammation; Interferon-gamma; Interleukin-6; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Molecular Structure; Peritonitis; Taurine; Thiadiazines; Zymosan | 2006 |
Mast cell-expressed complement receptor, not TLR2, is the main detector of zymosan in peritonitis.
Topics: Animals; Cell Movement; Complement Activation; Injections, Intraperitoneal; Leukocytosis; Leukotriene B4; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophils; Peritonitis; Receptor, Anaphylatoxin C5a; Receptors, Complement; Toll-Like Receptor 2; Zymosan | 2007 |
Resolvin E1 and protectin D1 activate inflammation-resolution programmes.
Topics: Animals; Apoptosis; Cell Movement; Docosahexaenoic Acids; Eicosapentaenoic Acid; Leukocytes; Lymph Nodes; Macrophages; Mice; Peritonitis; Phagocytosis; Spleen; Zymosan | 2007 |
ABCC transporter inhibition reduces zymosan-induced peritonitis.
Topics: Animals; Antigens, Differentiation; Bronchodilator Agents; Cell Movement; Chemotaxis, Leukocyte; Edema; Eicosanoids; Inflammation; Interleukin-1beta; Lipopolysaccharides; Luminescence; Macrophage Activation; Macrophages, Peritoneal; Male; Mice; Monocytes; Multidrug Resistance-Associated Proteins; Peritonitis; Propionates; Quinolines; Respiratory Burst; Tumor Necrosis Factor-alpha; Zymosan | 2007 |
Etanercept reduces acute tissue injury and mortality associated to zymosan-induced multiple organ dysfunction syndrome.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; bcl-2-Associated X Protein; Etanercept; Fas Ligand Protein; Immunoglobulin G; Inflammation; Mice; Mice, Knockout; Multiple Organ Failure; Peritonitis; Proto-Oncogene Proteins c-bcl-2; Receptors, Tumor Necrosis Factor; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Zymosan | 2008 |
Resident peritoneal leukocytes are important sources of MMP-9 during zymosan peritonitis: superior contribution of macrophages over mast cells.
Topics: Animals; Chemotaxis, Leukocyte; Leukocytes; Macrophages, Peritoneal; Male; Mast Cells; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Peritoneal Cavity; Peritonitis; RNA, Messenger; Zymosan | 2007 |
Acute peritonitis in a C57BL/6 mouse model of peritoneal dialysis.
Topics: Acute Disease; Animals; Dinoprostone; Disease Models, Animal; Escherichia coli; In Vitro Techniques; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Peritoneal Dialysis; Peritonitis; Vascular Endothelial Growth Factor A; Zymosan | 2007 |
Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome.
Topics: Animals; Gene Deletion; Interleukin-10; Interleukin-1beta; Kidney; Lipid Peroxidation; Liver; Mice; Mice, Knockout; Multiple Organ Failure; Neutrophil Infiltration; Nitrates; Nitrites; Pancreas; Peritonitis; Tumor Necrosis Factor-alpha; Zymosan | 2008 |
Gelatinase B/MMP-9 as an inflammatory marker enzyme in mouse zymosan peritonitis: comparison of phase-specific and cell-specific production by mast cells, macrophages and neutrophils.
Topics: Animals; Antibodies, Monoclonal; Biomarkers; Blotting, Western; Disease Models, Animal; Macrophages; Male; Mast Cells; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Neutrophils; Peritonitis; Zymosan | 2008 |
Synthetic chemerin-derived peptides suppress inflammation through ChemR23.
Topics: Animals; Anti-Inflammatory Agents; Antibodies; Chemokines; Chemotactic Factors; Chemotaxis; Inflammation; Intercellular Signaling Peptides and Proteins; Macrophage Activation; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Neutralization Tests; Peptides; Peritonitis; Protein Processing, Post-Translational; Receptors, Chemokine; Receptors, G-Protein-Coupled; Zymosan | 2008 |
Role and regulation of adipokines during zymosan-induced peritoneal inflammation in mice.
Topics: Adipokines; Adiponectin; Animals; Female; Leptin; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Neutrophil Infiltration; Obesity; Peritonitis; Resistin; Zymosan | 2008 |
Resistance to experimental peritonitis induced by local nonspecific stimulation of the reticuloendothelial system.
Topics: Animals; Dogs; Immunity; Injections, Intraperitoneal; Injections, Intravenous; Mononuclear Phagocyte System; Peritonitis; Postoperative Complications; Zymosan | 1980 |
Post-capillary venules in the "milky spots" of the greater omentum are the major site of plasma protein and leukocyte extravasation in rodent models of peritonitis.
Topics: Animals; Arthritis; Blood Flow Velocity; Blood Proteins; Disease Models, Animal; Indoles; Leukocytes; Male; Mice; Microscopy, Electron; Omentum; Organometallic Compounds; Peritoneum; Peritonitis; Pleurisy; Rats; Staining and Labeling; Venules; Zymosan | 1995 |
Measurement and drug induced modulation of interleukin-1 level during zymosan peritonitis in mice.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Biological Assay; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Indomethacin; Interleukin-1; Male; Mice; Peritonitis; Thiophenes; Zymosan | 1995 |
Characterization and pharmacological modulation of antigen-induced peritonitis in actively sensitized mice.
Topics: Animals; Benzeneacetamides; Cetirizine; Cycloheximide; Dexamethasone; Eosinophils; Histamine Release; Hydroxamic Acids; Indomethacin; Kinetics; Leukocyte Count; Leukotriene B4; Leukotriene C4; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred BALB C; Ovalbumin; Peritoneal Cavity; Peritonitis; Platelet Activating Factor; T-Lymphocytes; Tacrolimus; Terfenadine; Thiazoles; Zymosan | 1993 |
Comparison between lung and liver lipid peroxidation and mortality after zymosan peritonitis in the rat.
Topics: Analysis of Variance; Animals; Carbon Dioxide; Death; Lipid Peroxidation; Liver; Lung; Male; Oxygen; Partial Pressure; Peritonitis; Rats; Rats, Wistar; Zymosan | 1994 |
Administration of large doses of vitamin C does not decrease oxidant-induced lung lipid peroxidation caused by bacterial-independent acute peritonitis.
Topics: Acute Disease; Animals; Antioxidants; Ascorbic Acid; Ascorbic Acid Deficiency; Inflammation; Lipid Peroxidation; Lung; Male; Oxidation-Reduction; Peritonitis; Pulmonary Edema; Rats; Rats, Wistar; Vitamin E; Vitamin E Deficiency; Zymosan | 1994 |
Alpha-tocopherol attenuates lung edema and lipid peroxidation caused by acute zymosan-induced peritonitis.
Topics: Acute Disease; Animals; Ascorbic Acid; Catalase; Lipid Peroxidation; Lung; Male; Peritonitis; Pulmonary Edema; Rats; Rats, Wistar; Vitamin E; Zymosan | 1995 |
Role of beta 2 integrins in the recruitment of phagocytic cells in joint inflammation in the rat.
Topics: Animals; Antibodies, Monoclonal; Arthritis, Experimental; Female; Integrins; Male; Peritonitis; Phagocytes; Rats; Rats, Inbred Lew; Zymosan | 1994 |
Synthesis and 5-lipoxygenase inhibitory activities of some novel 2-substituted 5-benzofuran hydroxamic acids.
Topics: Animals; Benzofurans; Lipoxygenase Inhibitors; Male; Mice; Molecular Structure; Peritonitis; Structure-Activity Relationship; Zymosan | 1994 |
In vivo characterization of zymosan-induced mouse peritoneal inflammation.
Topics: Acetophenones; Animals; Arachidonate 5-Lipoxygenase; Benzopyrans; Complement C5a; Leukotriene B4; Male; Mast Cells; Mice; Peritonitis; Peroxidase; Tetrazoles; Zymosan | 1994 |
The effect of acute nonbacterial dependent peritonitis on lung and liver oxidant stress and antioxidant activity.
Topics: Animals; Antioxidants; Body Weight; Catalase; Diuresis; Glutathione; Glutathione Disulfide; Hematocrit; Liver; Lung; Male; Oxidants; Oxygen; Peritonitis; Rats; Rats, Wistar; Time Factors; Xanthine Dehydrogenase; Xanthine Oxidase; Zymosan | 1993 |
Relationship between liver oxidant stress and antioxidant activity after zymosan peritonitis in the rat.
Topics: Acidosis, Lactic; Animals; Antioxidants; Blood Gas Analysis; Disease Models, Animal; Glutathione; Inflammation; Liver; Male; Malondialdehyde; Oxidants; Oxygen Consumption; Peritonitis; Random Allocation; Rats; Rats, Sprague-Dawley; Time Factors; Xanthine Dehydrogenase; Xanthine Oxidase; Zymosan | 1993 |
Role of induced nitric oxide synthase and increased NO levels in zymosan peritonitis in the rat.
Topics: Animals; Arginine; Colchicine; Dexamethasone; Enzyme Induction; Enzyme Inhibitors; Escherichia coli; Lipopolysaccharides; Macrophages, Peritoneal; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peritonitis; Rats; Rats, Wistar; Zymosan | 1995 |
Alterations in endothelial barrier permeability in multiple organs during overactivation of macrophages in rats.
Topics: Animals; Blood-Brain Barrier; Capillary Permeability; Concanavalin A; Cytokines; Endothelium, Vascular; Injections, Intraperitoneal; Macrophage Activation; Macrophages, Peritoneal; Male; Peritonitis; Rats; Rats, Sprague-Dawley; Thioglycolates; Viscera; Zymosan | 1996 |
Propentofylline inhibits polymorphonuclear leukocyte recruitment in vivo by a mechanism involving adenosine A2A receptors.
Topics: Animals; Anti-Ulcer Agents; Male; Mice; Neutrophils; Peritonitis; Purinergic P1 Receptor Antagonists; Pyrazines; Receptor, Adenosine A2A; Receptors, Purinergic P1; Xanthines; Zymosan | 1996 |
Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses.
Topics: 5-Lipoxygenase-Activating Proteins; Anaphylaxis; Animals; Arachidonic Acid; Carrier Proteins; DNA, Complementary; Edema; Eicosanoids; Hypersensitivity, Delayed; Immunoglobulin E; Inflammation; Macrophages, Peritoneal; Membrane Proteins; Mice; Mice, Knockout; Peritonitis; Peroxidase; Platelet Activating Factor; RNA, Messenger; Transcription, Genetic; Zymosan | 1997 |
Role of nitric oxide in a nonseptic shock model induced by zymosan in the rat.
Topics: Acute Disease; Animals; Ascitic Fluid; Blood Pressure; Cardiovascular Diseases; Enzyme Inhibitors; Male; Nitrates; Nitric Oxide; Nitrites; Peritonitis; Rats; Rats, Sprague-Dawley; Shock; Vasomotor System; Zymosan | 1997 |
Inhibition of poly (ADP-ribose) synthetase attenuates neutrophil recruitment and exerts antiinflammatory effects.
Topics: Animals; Benzamides; Carrageenan; Cell Movement; Edema; Enzyme Inhibitors; Histocytochemistry; Inflammation; Lung; Male; Mice; Mice, Knockout; Multiple Organ Failure; Neutrophils; Peritonitis; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; Rats, Wistar; Zymosan | 1997 |
Multiple organ failure following zymosan-induced peritonitis is mediated by nitric oxide.
Topics: Acute Disease; Animals; Disease Models, Animal; Enzyme Induction; Injections, Intraperitoneal; Male; Multiple Organ Failure; Nitric Oxide; Nitric Oxide Synthase; Peritonitis; Random Allocation; Rats; Rats, Sprague-Dawley; Zymosan | 1997 |
Endogenous monocyte chemoattractant protein-1 recruits monocytes in the zymosan peritonitis model.
Topics: Acute Disease; Animals; Chemokine CCL2; Chemotaxis, Leukocyte; Dexamethasone; Disease Models, Animal; Glucocorticoids; Macrophage-1 Antigen; Male; Mice; Monocytes; Peritonitis; Vinblastine; Zymosan | 1998 |
Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice.
Topics: Animals; Ascitic Fluid; Female; Leukocyte Count; Macrophages, Peritoneal; Male; Mice; Mice, Knockout; Peritoneum; Peritonitis; Phagocytosis; Plasminogen; Thioglycolates; Zymosan | 1998 |
Stem cell factor-deficient mice have a dysregulation of cytokine production during local inflammation.
Topics: Animals; Ascitic Fluid; Body Weight; Cytokines; Disease Models, Animal; Female; Hypoglycemia; Inflammation; Irritants; Mice; Mice, Mutant Strains; Peritoneal Cavity; Peritonitis; Stem Cell Factor; Turpentine; Weight Loss; Zymosan | 1998 |
Effect of obstructive jaundice on neutrophil chemotactic activity: an in vivo assessment in zymosan-induced peritonitis model in rats.
Topics: Animals; Ascitic Fluid; Chemotaxis, Leukocyte; Cholestasis; Disease Models, Animal; Injections, Intraperitoneal; Male; Neutrophils; Peritoneal Lavage; Peritonitis; Peroxidase; Rats; Rats, Wistar; Zymosan | 1998 |
Protective effect of melatonin in a non-septic shock model induced by zymosan in the rat.
Topics: Acute Disease; Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Chemotaxis, Leukocyte; Dose-Response Relationship, Drug; Free Radical Scavengers; Ileum; Immunoenzyme Techniques; Intestinal Diseases; Intestinal Mucosa; Liver Diseases; Lung Diseases; Male; Melatonin; Neutrophils; Nitrates; Nitrites; Peritonitis; Peroxidase; Random Allocation; Rats; Rats, Sprague-Dawley; Saccharomyces cerevisiae; Zymosan | 1998 |
Role of inducible nitric oxide synthase in the regulation of neutrophil migration in zymosan-induced inflammation.
Topics: Animals; Chemokine CCL2; Chemokine CCL3; Chemokine CCL4; Chemokine CXCL1; Chemokine CXCL2; Chemokines; Chemokines, CXC; Chemotactic Factors; Chemotaxis, Leukocyte; Growth Inhibitors; Growth Substances; Intercellular Signaling Peptides and Proteins; Interleukin-10; Macrophage Inflammatory Proteins; Mice; Mice, Knockout; Models, Immunological; Monokines; Neutrophils; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peritonitis; Time Factors; Zymosan | 1998 |
Regulation of macrophage inflammatory protein-1 alpha expression and function by endogenous interleukin-10 in a model of acute inflammation.
Topics: Acute Disease; Animals; Cell Movement; Chemokine CCL3; Chemokine CCL4; Disease Models, Animal; Injections, Intraperitoneal; Interleukin-10; Leukocyte Count; Macrophage Inflammatory Proteins; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Neutrophils; Peritonitis; Zymosan | 1999 |
Role of interleukin-6 in a non-septic shock model induced by zymosan.
Topics: Animals; Antibodies, Monoclonal; Ascites; Ascitic Fluid; DNA Damage; Energy Metabolism; Injections, Intraperitoneal; Interleukin-6; Intestine, Small; Leukocyte Count; Lipid Peroxidation; Liver; Lung; Macrophage Activation; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Mice, Knockout; Multiple Organ Failure; NAD; Neutrophils; Nitrates; Nitrites; Oxidative Phosphorylation; Peritonitis; Peroxidase; Shock; Tyrosine; Zymosan | 1999 |
Protective effect of N-acetylcysteine on multiple organ failure induced by zymosan in the rat.
Topics: Acetylcysteine; Animals; Body Weight; Disease Models, Animal; Drug Evaluation, Preclinical; Free Radical Scavengers; Leukocyte Count; Male; Multiple Organ Failure; Nitrates; Nitric Oxide; Peritonitis; Random Allocation; Rats; Rats, Sprague-Dawley; Shock, Septic; Survival Analysis; Time Factors; Zymosan | 1999 |
Protective effect of poly(ADP-ribose) synthetase inhibition on multiple organ failure after zymosan-induced peritonitis in the rat.
Topics: Animals; Benzamides; Body Weight; Disease Models, Animal; Drug Evaluation, Preclinical; Male; Multiple Organ Failure; Niacinamide; Nitrates; Peritonitis; Poly(ADP-ribose) Polymerase Inhibitors; Random Allocation; Rats; Rats, Sprague-Dawley; Time Factors; Zymosan | 1999 |
Peritoneal lymphatic absorption and solute exchange during zymosan-induced peritonitis in the rat.
Topics: Animals; Capillary Permeability; Lymph; Lymphatic System; Male; Peritonitis; Rats; Rats, Wistar; Zymosan | 1999 |
Elucidation of the early events contributing to zymosan-induced multiple organ dysfunction syndrome using MIP-1alpha, C3 knockout, and C5-deficient mice.
Topics: Animals; Chemokine CCL3; Chemokine CCL4; Complement Activation; Complement C3; Complement C5; Disease Models, Animal; Exudates and Transudates; Injections, Intraperitoneal; Kidney; Leukocyte Count; Lung; Macrophage Inflammatory Proteins; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Mice, Mutant Strains; Multiple Organ Failure; Myocardium; Neutrophil Infiltration; Peritonitis; Spleen; Transaminases; Zymosan | 1999 |
Role of hyperbaric oxygen exposure in reduction of lipid peroxidation and in multiple organ failure induced by zymosan administration in the rat.
Topics: Animals; Hyperbaric Oxygenation; Lipid Peroxidation; Male; Malondialdehyde; Multiple Organ Failure; Peritonitis; Peroxidase; Rats; Rats, Sprague-Dawley; Tyrosine; Zymosan | 2000 |
Genetic factors determine the contribution of leukotrienes to acute inflammatory responses.
Topics: Acute Disease; Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Crosses, Genetic; Ear, External; Edema; Indomethacin; Inflammation; Leukotriene C4; Leukotrienes; Mice; Mice, Congenic; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Mutant Strains; Peritonitis; Species Specificity; Zymosan | 2000 |
Generation of pro-inflammatory and anti-inflammatory cytokines in the gut in zymosan-induced peritonitis.
Topics: Animals; Digestive System; Interleukin-10; Interleukin-6; Male; Mesenteric Veins; Mesentery; Peritonitis; Rats; Rats, Wistar; Time Factors; Tumor Necrosis Factor-alpha; Zymosan | 2000 |
21-NO-prednisolone is a novel nitric oxide-releasing derivative of prednisolone with enhanced anti-inflammatory properties.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Granuloma; Humans; Inflammation; Interleukin-1; Leukocytes, Mononuclear; Male; Mice; Nitric Oxide; Peritonitis; Prednisolone; Receptors, Cell Surface; Treatment Outcome; Zymosan | 2000 |
Role of mast cells in zymosan-induced peritoneal inflammation in Balb/c and mast cell-deficient WBB6F1 mice.
Topics: Animals; Anti-Asthmatic Agents; Cimetidine; Cromolyn Sodium; Histamine Antagonists; Hypoglycemic Agents; Mast Cells; Mice; Mice, Inbred BALB C; Mice, Knockout; Peritonitis; Pyrilamine; Ranitidine; Receptors, Histamine; Triprolidine; Zymosan | 2001 |
Inducible nitric oxide synthase knockout mice exhibit resistance to the multiple organ failure induced by zymosan.
Topics: Animals; Enzyme Inhibitors; Exudates and Transudates; Guanidines; Lipid Peroxidation; Liver; Lung; Macrophages, Peritoneal; Male; Mice; Mice, Knockout; Multiple Organ Failure; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Peritonitis; Peroxidase; Poly(ADP-ribose) Polymerases; Rhodamines; Shock; Tyrosine; Zymosan | 2001 |
Critical role of mast cells in morphine-mediated impairment of zymosan-induced peritonitis in mice.
Topics: Analgesics, Opioid; Animals; Anti-Inflammatory Agents; Bone Marrow Cells; Capillary Permeability; Cell Count; Chemotaxis, Leukocyte; Histamine; Male; Mast Cells; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Morphine; Naltrexone; Narcotic Antagonists; Peritonitis; Zymosan | 2001 |
15-Deoxy-delta(12,14)-prostaglandin J2 is a negative regulator of macrophage functions.
Topics: Animals; Cell Adhesion; Chemotaxis; Escherichia coli; Hydrogen Peroxide; Inflammation; Ligands; Lipopolysaccharides; Macrophage-1 Antigen; Macrophages, Peritoneal; Male; Oxidative Stress; Peritonitis; Phagocytosis; Prostaglandin D2; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Superoxides; Tetradecanoylphorbol Acetate; Transcription Factors; Zymosan | 2001 |
Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Capillary Leak Syndrome; Capillary Permeability; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cysteine; Diterpenes; Eicosanoids; Enzyme Induction; Ginkgolides; Histamine Release; Indoles; Indomethacin; Isoenzymes; Lactones; Leukotriene C4; Leukotrienes; Lipoxygenase Inhibitors; Macrophages, Peritoneal; Male; Mast Cells; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Mutant Strains; Nitrobenzenes; Peritonitis; Phospholipid Ethers; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Quinolines; Sulfonamides; Thioglycolates; Zymosan | 2002 |
Altered neutrophil function in the neonate protects against sepsis-induced lung injury.
Topics: Animals; Animals, Newborn; Chemokine CXCL2; Leukocyte Count; Lung; Monokines; Neutrophils; Peritonitis; Pulmonary Edema; Rats; Sepsis; Zymosan | 2002 |
Morphine attenuates pain and prevents inflammation in experimental peritonitis.
Topics: Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Dose-Response Relationship, Drug; Enkephalins; Leukocytes; Morphine; Pain; Peritonitis; Protein Precursors; Zymosan | 2002 |
The tyrosine kinase inhibitor tyrphostin AG 126 reduces the multiple organ failure induced by zymosan in the rat.
Topics: Animals; Enzyme Inhibitors; Male; Models, Animal; Multiple Organ Failure; Nitric Oxide; Peritonitis; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Tyrphostins; Zymosan | 2002 |
Evaluation of the mechanism of zymosan-induced resistance to experimental peritonitis.
Topics: Animals; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Hemoglobins; Humans; Injections, Intraperitoneal; Leukocytes; Monocytes; Mononuclear Phagocyte System; Peritonitis; Phagocytosis; Rats; Zymosan | 1978 |
Enhancement of local immune response in the treatment of experimental peritonitis.
Topics: Animals; Ascitic Fluid; Dipeptides; Escherichia coli Infections; Leukocyte Count; Methionine; N-Formylmethionine; Peritonitis; Phagocytosis; Rats; Thioglycolates; Zymosan | 1979 |
Intestinal smooth muscle dysfunction after intraperitoneal injection of zymosan in the rat: are oxygen radicals involved?
Topics: Animals; Cyclic AMP; Free Radicals; Glutathione; In Vitro Techniques; Intestine, Small; Isoproterenol; Male; Methacholine Chloride; Muscle Contraction; Muscle, Smooth; Oxygen; Peritonitis; Peroxidase; Rats; Rats, Inbred Strains; Zymosan | 1992 |
Time-dependent alterations of leukotriene production and catabolism in rat peritoneal macrophages following intraperitoneal injection of thioglycollate broth.
Topics: Animals; Arachidonic Acid; Calcimycin; Cell Count; gamma-Glutamyltransferase; Leukotriene B4; Macrophage Activation; Macrophages; Male; Membrane Lipids; Peritonitis; Rats; Rats, Inbred Strains; SRS-A; Thioglycolates; Time Factors; Zymosan | 1992 |
Lung oxidant changes after zymosan peritonitis: relationship between physiologic and biochemical changes.
Topics: Animals; Blood Gas Analysis; Catalase; Disease Models, Animal; Evaluation Studies as Topic; Glutathione; Glutathione Disulfide; Inflammation; Lipid Peroxidation; Male; Malondialdehyde; Oxygen Consumption; Peritonitis; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Time Factors; Xanthine Dehydrogenase; Xanthine Oxidase; Zymosan | 1992 |
The anti-inflammatory effect of erythromycin in zymosan-induced peritonitis of mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Ascitic Fluid; Blood Proteins; Dinoprostone; Disease Models, Animal; Erythromycin; Female; Mice; Peritonitis; Time Factors; Treatment Failure; Zymosan | 1992 |
Selective decontamination of the digestive tract prevents secondary infection of the abdominal cavity, and endotoxemia and mortality in sterile peritonitis in laboratory rats.
Topics: Animals; Anti-Bacterial Agents; Colistin; Digestive System; Endotoxins; Feces; Gram-Negative Bacteria; Gram-Positive Bacteria; Peritonitis; Rats; Tobramycin; Zymosan | 1992 |
Evidence that endogenous interleukin-1 is involved in leukocyte migration in acute experimental inflammation in rats and mice.
Topics: Animals; Ascitic Fluid; Chemotaxis, Leukocyte; Inflammation; Interleukin-1; Kinetics; Male; Mice; Peritonitis; Pleural Effusion; Pleurisy; Rats; Rats, Inbred Strains; Zymosan | 1992 |
K562 cells produce an anti-inflammatory factor that inhibits neutrophil functions in vivo.
Topics: Animals; Anti-Inflammatory Agents; Caseins; Cell Adhesion; Cell Degranulation; Cytokines; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred BALB C; Neutrophils; Opsonin Proteins; Peritonitis; Tumor Cells, Cultured; Zymosan | 1992 |
Enhancement of normal polymorphonuclear cells respiratory burst in ascitic fluid by fibronectin. Comparison between cirrhotic and malignant ascitic fluids.
Topics: Adult; Aged; Aged, 80 and over; Ascitic Fluid; Bacterial Infections; Disease Susceptibility; Dose-Response Relationship, Drug; Female; Fibronectins; Humans; Liver Cirrhosis; Luminescent Measurements; Middle Aged; Neutrophils; Ovarian Neoplasms; Peritonitis; Respiratory Burst; Risk Factors; Stomach Neoplasms; Tetradecanoylphorbol Acetate; Zymosan | 1992 |
A comparison of the anti-inflammatory activity of selective 5-lipoxygenase inhibitors with dexamethasone and colchicine in a model of zymosan induced inflammation in the rat knee joint and peritoneal cavity.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arthritis; Benzeneacetamides; Calcimycin; Colchicine; Dexamethasone; Dinoprostone; Disease Models, Animal; Hydroxamic Acids; Inflammation; Kinetics; Knee Joint; Leukocytes; Leukotriene B4; Leukotrienes; Lipoxygenase Inhibitors; Male; Peritonitis; Pyrazoles; Rats; Zymosan | 1991 |
The antinociceptive activity of paracetamol in zymosan-induced peritonitis in mice: the role of prostacyclin and reactive oxygen species.
Topics: 6-Ketoprostaglandin F1 alpha; Acetaminophen; Analgesics; Animals; Dinoprostone; Epoprostenol; Free Radicals; Iloprost; Lipid Peroxides; Luminescent Measurements; Macrophages; Male; Mice; Peritonitis; Platelet Aggregation Inhibitors; Superoxides; Zymosan | 1990 |
Does selective decontamination of the gastrointestinal tract prevent multiple organ failure? An experimental study.
Topics: Animals; Digestive System; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Lymph Nodes; Male; Mesentery; Multiple Organ Failure; Peritonitis; Rats; Rats, Inbred Strains; Streptomycin; Survival Rate; Trimethoprim; Zymosan | 1991 |
Kinetics of phospholipase A2, arachidonic acid, and eicosanoid appearance in mouse zymosan peritonitis.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Ascitic Fluid; Chromatography, High Pressure Liquid; Eicosanoids; Exudates and Transudates; Gas Chromatography-Mass Spectrometry; Male; Mice; Mice, Inbred Strains; Peritonitis; Phospholipases; Phospholipases A; Phospholipases A2; Radioimmunoassay; Time Factors; Zymosan | 1990 |
Extracellular phospholipase A2 activity in two in vivo models of inflammation.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Ascitic Fluid; Calcium; Caseins; Disease Models, Animal; Extracellular Space; Hydrogen-Ion Concentration; Kinetics; Male; Mice; Peritoneal Lavage; Peritonitis; Phospholipases A; Phospholipases A2; Rats; Rats, Inbred Lew; Zymosan | 1990 |
SOD in rat models of shock and organ failure.
Topics: Animals; Body Weight; Cattle; Disease Models, Animal; Lipid Peroxidation; Liver; Male; Multiple Organ Failure; Peritonitis; Rats; Rats, Inbred Strains; Shock; Shock, Septic; Superoxide Dismutase; Zymosan | 1990 |
A novel neutrophil chemoattractant generated during an inflammatory reaction in the rabbit peritoneal cavity in vivo. Purification, partial amino acid sequence and structural relationship to interleukin 8.
Topics: Amino Acid Sequence; Animals; Chemotactic Factors; Edema; Electrophoresis, Polyacrylamide Gel; Inflammation; Interleukin-8; Molecular Sequence Data; Neutrophils; Peritonitis; Rabbits; Sodium Dodecyl Sulfate; Zymosan | 1990 |
Kinins and peritoneal exudates induced by carrageenin and zymosan in rats.
Topics: Animals; Ascitic Fluid; Carrageenan; Edema; Kininogens; Kinins; Peritonitis; Rats; Rats, Inbred BN; Rats, Inbred Strains; Zymosan | 1990 |
Extracellular phospholipase A2 activity in cell free peritoneal lavage fluid from mice with zymosan peritonitis.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Male; Mice; Peritonitis; Phospholipases; Phospholipases A; Phospholipases A2; SRS-A; Therapeutic Irrigation; Time Factors; Zymosan | 1989 |
Chemotactic responses of neutrophils in cats with spontaneous feline infectious peritonitis.
Topics: Animals; Ascitic Fluid; Cat Diseases; Cats; Chemotaxis, Leukocyte; Female; Male; Neutrophils; Peritonitis; Zymosan | 1989 |
[Stimulation of nonspecific immune defense and antibody synthesis with zymosan].
Topics: Animals; Antibody Formation; Bacterial Infections; Erythrocytes; Immunity, Innate; Mice; Peritonitis; Zymosan | 1989 |
Complement activation in peritonitis. Association with hepatic and renal perfusion abnormalities. First place winner: Conrad Jobst award.
Topics: Animals; Complement Activation; Elapid Venoms; Female; Liver Circulation; Male; Multiple Organ Failure; Peritonitis; Rats; Rats, Inbred Strains; Renal Circulation; Time Factors; Vascular Resistance; Zymosan | 1987 |
Kinetics of the generation and action of chemical mediators in zymosan-induced inflammation of the rabbit peritoneal cavity.
Topics: Animals; Blood Proteins; Complement C5; Complement C5a; Exudates and Transudates; In Vitro Techniques; Kinetics; Male; Neutrophils; Peritonitis; Prostaglandins; Rabbits; Radioimmunoassay; Zymosan | 1986 |
Inhibition of carrageenan-induced acute inflammation in mice by oral administration of anthocyanin mixture from wild mulberry and cyanidin-3-glucoside.
Topics: Acute Disease; Administration, Oral; Animals; Anthocyanins; Carrageenan; Edema; Glucosides; Inflammation; Male; Mice; Morus; Neutrophils; Peritonitis; Plant Extracts; Time Factors | 2013 |